sedoheptulose bisphosphate bypass

MetaCyc:PWY0-1517

This ATP-dependent two-event bypass converts sedoheptulose7-phosphate (S7P) through sedoheptulose1, 7-bisphosphate (SBP) to erythrose4-phosphate (E4P) and glycerone phosphate (DHAP). Exact Rhea chemistry is S7P + ATP -> SBP + ADP + H(+), followed by SBP -> E4P + DHAP. Native RXN0-6541 and SEDOBISALDOL-RXN map to directional RHEA31444 and cleavage30169; native 30170 is bidirectional and 30168 is condensation. The generic S7P class is distinct from alpha-pyranose CPD-19339/CHEBI133984. PfkA is a native homotetramer and FbaA a homodimer, not the mixed PfkA/PfkB assembly suggested by the frozen PathBank component list. Reference P0A796/b3916 and P0AB71/b2925 and MG1655 GeneIDs948412/947415 anchor identity; off-taxon GeneIDs93777982/93779073 belong to Shigella sonnei and are rejected. Database taxonomic range and reference identity do not establish unmodified wild-type flux in every strain. [EcoCyc:6PFK-1-CPX; EcoCyc:FRUCBISALD-CLASSII; EcoCyc:PWY0-1517; Entrez:947415; Entrez:948412; MetaCyc:CPD-19339; MetaCyc:D-SEDOHEPTULOSE-1-7-P2; MetaCyc:D-SEDOHEPTULOSE-7-P; MetaCyc:PWY0-1517; MetaCyc:RXN0-6541; MetaCyc:SEDOBISALDOL-RXN; PathBank:SMP0002110; RHEA:30169; RHEA:31444; UniProtKB:P0A796; UniProtKB:P0AB71] PMID19756045 studies BW25113 talA:tet/talB:Cm derivatives, not a sequenced MG1655 assay strain. The double deletion grows on xylose (doubling time110 min versus 100 min wild type); additional pfkA deletion abolishes this growth. deoBC, fbp and tpiA comparisons distinguish alternative routes, with the paper's data-not-shown limitations retained. Growth screening, metabolomics and enzyme assays have distinct media/carbon concentrations. Cultures were at 37 °C, generally in MOPS medium; a common universal medium is not inferred. [PMID:19756045] The 2009 direct assay uses six-His ASKA PfkA/FbaA, 2 µM enzyme, 5 mM S7P or F6P, 2 mM ATP and 50 mM potassium MOPS at 37 °C for 1 h (five samples). TableIII separates no-enzyme S7P 5.13±0.26 mM with products not detected; PfkA-only S7P 2.91±0.15/SBP 1.15±0.13; both enzymes S7P 3.05±0.14/SBP 0.79±0.11/DHAP0.23±0.02/E4P0.39±0.03; FbaA-only S7P 5.27±0.17 with products not detected; and the F6P comparison yielding FBP/DHAP with E4P not determined. No authentic SBP standard was available: migration reasoning and F1, 6BP calibration were used. Results report m/z369.0 and Methods367.0, an unresolved internal discrepancy rather than a silently corrected observation. [PMID:19756045] The 2009 original supplementary workbooks retain S7P accumulation of about 45.67-fold on xylose and 101.63-fold on gluconate for the selected mutant/wild-type columns. The description of no notable transcriptional change differs from literal equality: fbaA ratio 1.18 and pfkA1.241 are retained. Isotopomer model fits support the bypass in tested talAB cells; with uptake normalized100, wild-type best-fit bypass values are small nonzero0.004/0.005 and the mutant both-pathway fit is about 29.923/29.181. These are model-specific relative fluxes. Some supplementary MFA equations label the SBP-cleavage product GAP/G3P rather than DHAP; direct products and Rhea define the chemistry, and no TPI event is added to repair a source model. [PMID:19756045] Supplementary Figure 8 of PMID19756045 uses the Lactococcus lactis pfk ORF in pTRC99A under a trc promoter to complement the E. coli talAB pfkA triple-mutant xylose phenotype (MOPS, 0.2% xylose, 1 mM IPTG). The donor strain/accession is not supplied. This is heterologous complementation, not native L. lactis complete-pathway flux or a reference-protein sequence assignment. [PMID:19756045] PMID31871051 reconstructs BW25113 talAB and measures xylose growth at 0.33±0.01 h−1 versus wild type 0.39±0.01 in M9; glucose values are0.52 versus 0.49 h−1. Its knockout Methods inconsistently mention pKD3 and pKD4. Orbitrap identification at 368.99 [M-H]− with 199/271 fragments uses mutant extract as a control, not an authentic commercial SBP standard. SBP stability limits, a blank368.804 peak and trace wild-type xylose SBP remain explicit; metabolite detection does not measure wild-type bypass flux. Its PfkA BW25113_3916 in pET-28b(+), DH5α cloning, Rosetta expression and His-affinity purification is separate from the 2009 ASKA preparation. [PMID:31871051] The 2020 E. coli PfkA comparison at 55 °C reports F6P apparent Km 0.065 mM/kcat 1.2 s−1 versus S7P 2.5 mM/0.25 s−1. Tabulated S7P efficiency0.15×10^3 differs from arithmetic using the rounded values and is not replaced. The coupled assay includes Mg 5 mM, ATP 2 mM, ADP 0.25 mM, rabbit aldolase4 U/ml, G3PDH2 U/ml and NADH0.15 mM. S7P was supplied as a Ba salt; this reagent form is retained as assay context, not a new core species. No TPI was added; trace TPI is a suggested explanation for unequal downstream peaks, not a new E. coli core participant. The separately cited2020 thesis DOI10.18174/510683 chapter6 supplement is not asserted byte-identical to the inaccessible journal supplement. PDF137 FigureS1 is a no-enzyme control; PDF140 FigureS4 shows both Michaelis–Menten S7P Km 2.489181822 mM and Hill K1/2=1.24179394 mM, n=1.603138135. Raw Vmax in dAbs/min is not kcat, and the fit comparison does not establish physiological bypass cooperativity. [DOI:10.18174/510683; PMID:31871051] The clostridial PPi-dependent six-event MetaCycPWY-8178 definition is a separate pathway. Added rabbit aldolase in the 2020 coupling assay does not characterize a particular native clostridial aldolase. C. thermosuccinogenes ATP/GTP-PFK CDQ83_07225 showed no S7P activity up to 4 mM; its F6P ammonium dependence, very high Hill coefficient and proposed relief-valve role concern another enzyme and remain a hypothesis. The later engineered-clostridial LL1660 result (PMID36286488) removes both PPi-pfk and introduced TAL, limiting claims of universal necessity; the alternative C6↔C5 route remains unresolved. That result does not refute the E. coli ATP bypass assays. [MetaCyc:PWY-8178; MetaCyc:RXN-21730; PMID:31871051; PMID:36286488] PfkA annotation supports Mg dependence, homotetramer and cytoplasmic location. Canonical F6P-dependent activity is inhibited by PEP and activated by ADP/GDP; F6P has a cooperative substrate response whereas ATP does not in the cited native context. These signs, the >90% contribution to wild-type canonical PFK activity, pH effects and in-vitro reverse activity are not direct measurements of S7P regulation or whole-pathway flux. S7P turnover and F6P turnover are separate substrate contexts. [EcoCyc:6PFK-1-CPX; EcoCyc:6PFRUCTPHOS-ENZRXN; EcoCyc:REG0-7473; EcoCyc:REG0-7474; EcoCyc:REG0-7475; EcoCyc:REG0-7476; UniProtKB:P0A796] FbaA is a cytosolic class-II metal-dependent dimer. Native location/GO annotation is independent of SUBUNIT text. Two Zn sites per subunit (catalytic and structural) in the current annotation differ from the older PMID8436219 abstract's two Zn per dimer. The 2011 study (PMID22014167;2012 issue) separates untagged MG1655/pLEM1/pWKS30 material≥70% pure from pLEM5/pET28b His 6 WT and site mutants≥95% pure. As-purified metal content was up to 0.3 Zn/0.2 Ni per monomer; denaturation-assisted Zn loading produced2.3 Zn per monomer and 3.8-fold higher activity. Source numbering follows removed initiating methionine: His 110/226/264 catalytic ligands and Asp144/Glu174/Glu181 secondary-site ligands; historical His 108/111 is not silently renumbered. Native Co/Fe/Mn active metalloprotein alternatives are distinct from additive metal effects. Ni inhibits, Cu2+ strongly inhibits in vitro, low Zn slightly activates/high Zn slightly inhibits, Co slightly activates, and Ca/Mg/Mn had no effect in the measured preparation. Cytoplasmic copper is mainly cuprous, limiting physiological Cu2+ claims. Native K/ammonium activation cites personal communication in 1996; Ni/EDTA effects and earlier Crookes preparations remain source qualified. [EcoCyc:F16ALDOLASE-ENZRXN-CLASSII; EcoCyc:FRUCBISALD-CLASSII; EcoCyc:FRUCTBISALD-CLASSII-MONOMER; EcoCyc:REG0-12167; EcoCyc:REG0-12168; EcoCyc:REG0-12169; EcoCyc:REG0-8470; PMID:22014167; PMID:6996735; PMID:8436219; UniProtKB:P0AB71] In PMID22014167, untagged FbaA 20 nM challenged with Ni 16 µM is protected by His 100 µM (about 20% loss instead of 70%); GSH 1 mM enhances Ni inhibition. These are conditional activity effects relative to Ni-only challenge, not generic ligand activation/inhibition or direct FbaA binding. The rcnA/gshA comparisons and D 144A/E174A resistance support contributions of cellular ligands and the secondary metal site without uniquely proving a Ni-delivery mechanism. Source-native His/GSH formula, charge and InChI ground selected reference chemical identities, while the assay ionic form remains unstated; inconsistent native CML SMILES is retained as a conflict. MG1655 growth inhibition at 8 µM Ni depends on carbon source (glucose/fructose versus glycerol/lactate/succinate), is bacteriostatic, and FbaA activity recovers after Ni removal even with translation inhibited. Active versus passive repair remains unresolved. [PMID:22014167] UniProt FUNCTION text names GAP+E4P for SBP cleavage whereas its structured reaction and the 2009 direct assay support DHAP+E4P. Abstract-level PMID7872790 supports carbonyl substrate forms, Zn-dependent enediol(ate)-DHAP chemistry and pH effects; Cd replacement structures (PMID12595741) do not prove a physiological Cd cofactor or inhibition. Earlier phosphate-associated labeling (PMID3281666) and the later +76-Da mercaptoethanol adduct at source Cys36 (PMID7851430) concern different preparations; the latter ruled out phosphorylation and found no significant activity effect. Later phosphoproteome annotation (PMID35636362) does not reconcile these as a single constitutively modified active chain. Synthetic N-sulfonyl hydroxamate phosphate inhibitors and weaker phosphonate isosteres (PMID16236509) are bounded canonical-FBP context without an invented exact inhibitor identity. [EcoCyc:FRUCBISALD-CLASSII; PMID:12595741; PMID:16236509; PMID:19756045; PMID:3281666; PMID:35636362; PMID:7851430; PMID:7872790; UniProtKB:P0AB71] PMID31464375 uses His-tagged ASKA proteins (>90% purity;0.1 mM IPTG, 16 h at 37 °C, TALON purification). The 2019 NMR assay (15 µM monomer equivalent, 200 µM metabolites, 298 K; RF threshold0.1805/FPR5%) lists eleven FbaA binders:3PG, 6PG, AMP, ATP, citrate, GTP, malonate, NADP, PEP, PRPP and phenylpyruvate; six PfkA binders are AMP, CTP, FAD, FBP, GTP and NAD. These observations have no assigned causal sign merely from binding. The 2016 NMR paper PMID27065204 remains abstract/native scope; different buffers and thresholds limit direct comparison of binder sets. [PMID:27065204; PMID:31464375] The 2019 direct FbaA assay uses canonical FBP 1 mM, Tris10 mM pH7.5/Mg 1 mM at 30 °C,≈1 µM enzyme monomer equivalent, modifiers5 mM (hypoxanthine3.22 mM), triplicate activities and quadruplicate mixture-specific MS calibration. ATP, 3PG and PEP activate; hypoxanthine and IMP have no effect. MS combines same-mass DHAP/GAP signals. ATP is within the cited physiological range, whereas 3PG/PEP are above it. The source reports prior3PG inhibition, while the 1995 abstract PMID7872790 reports no effect from glycolytic intermediates/ATP. These source/assay-specific outcomes remain separate, and the appendix's generic inhibitor caption does not reverse measured activation. None directly measures SBP cleavage regulation. [PMID:31464375; PMID:7872790] Cra/FruR native PC00061 is a tetramer; the 1994 pT7-5 six-His assembly/ace-operator preparation (PMID8195118) differs from 1996 six-His binding-site/pfkA work (PMID8858581). Native pfkA regulatory records share siteBS785, and epd promoter records share BS264; epd-pgk-fbaA operon membership carries the fbaA expression interpretation. Cra-CPLX127 includes a native beta-D-fructofuranose1P component without a supplied ligand coefficient. Generic F1P assay identity is not assigned the native beta anomer. The 2018 abstract PMID29923648 reports F1P-dependent impairment of Cra DNA binding and negative FBP binding/effect tests, contrasting older FBP-effector discussion and the contaminant explanation in PMID30019355. Full2018 methods were unavailable. The 2021 Cra Asn50 cleavage/NTD behavior (PMID34666048) is a later preparation context, not proof that earlier specimens were cleaved. [EcoCyc:CPLX-127; EcoCyc:D-fructofuranose-1-phosphate; EcoCyc:FRU1P; EcoCyc:PC00061; EcoCyc:PD00521; EcoCyc:REG0-15081; EcoCyc:REG0-15233; EcoCyc:REG0-4838; EcoCyc:REG0-5630; PMID:19838295; PMID:29923648; PMID:30019355; PMID:34666048; PMID:8195118; PMID:8577250; PMID:8858581] Native CRP-cAMP CPLX0-226 contains CRP dimerPC00004 and cAMP; PC00004 has two P0ACJ8 chains, but ligand stoichiometry is not supplied. Positive epd-pgk-fbaA regulation is limited by the 1998 PMID9851989 abstract: deleting the CRP site had little effect under glucose whereas crp/cya loss strongly reduced epd/gapB P0, supporting an indirect response. PtsG-encoded IICBGlc contributes to glucose stimulation of that promoter. It is distinct from crr/EIIAGlc, does not establish a direct fbaA operator and is not a pathway-specific S7P transporter. [EcoCyc:CAMP; EcoCyc:CPLX0-226; EcoCyc:PC00004; EcoCyc:PD00257; EcoCyc:REG0-15234; EcoCyc:REG0-5629; Entrez:945295; Entrez:945651; PMID:9851989; UniProtKB:P0A9A9; UniProtKB:P0A9E5; UniProtKB:P13445; UniProtKB:P69783; UniProtKB:P69786; UniProtKB:P69913] PMID19838295 compares JM101-derived PB11/PB12 ΔptsH ptsI crr backgrounds and rpoS derivatives under aerobic M9 glucose conditions, distinct from BW25113 talAB. Its pET28b+/ER2566 His-RpoS or His-RpoD combined with commercial RNAP core at core:sigma1:5 supports direct transcription of the first pfkA promoter. A sigma chain is not an autonomous polymerase. fbaA expression is condition-specific and can be operon-mediated; no immediate fbaA promoter was found in the tested analysis, which is not general promoter absence. Original MG1665 and pykA/pfkA-label discrepancies remain source errors rather than reference-strain reassignments. PMID16102000 abstract describes epd-pgk-fbaA cotranscription, RNaseE cleavage and segment stability without a uniquely determined signed RNaseE effect on FbaA catalysis. [PMID:16102000; PMID:19838295] The csrA51 hypomorph in M9 glucose has reduced PfkA expression and partial growth/stress rescue after PfkA restoration (PMID26833659 plus native annotation). This is positive expression context, not a clean csrA deletion or a mapped direct RNA-binding site. Acid-associated pfkA response under aerobic but not microaerobic conditions is retained at abstract/native scope (PMID23274360), without assigning an unmeasured PhoB binding mechanism. [EcoCyc:6PFK-1-CPX; EcoCyc:TU0-45239; Entrez:947176; PMID:23274360; PMID:26833659] PMID21272324 uses BW25113 Keio cyoA(JW0422), cydB(JW0723), fnr(sourceJW1318) and fur(JW0669) deletions in continuous aerobic culture (D 0.2 h−1, 37 °C, pH7, DO35–40%; C/N 1.68 or8.42). RT-PCR, with source controls, reports increased pfkA expression in the relevant deletion comparisons, amid broad network changes. Negative reference-associated effects are therefore qualified indirect knockout inferences, not direct pfkA binding. The source Fnr gene contrast under oxygen does not identify a purified anaerobic [4Fe-4S] active species, and CyoA/CydB reference chains do not autonomously reproduce their respiratory complexes. Exact subject-reference genes and the pfkA object gene are separately grounded. [Entrez:945295; Entrez:945651; Entrez:945908; PMID:21272324; UniProtKB:P0ABJ1; UniProtKB:P0ABK2] Frozen PathBank memberPW002098.owl/rootSMP0002110 attaches Pentose PhosphateSMP0121065 (S7P-input/E4P-output context) and Glycolysis and Pyruvate DehydrogenaseSMP0000807 (DHAP-output context). Their generic Interaction markers are unsigned structural membership, not transport or inhibition. Exact local compounds remain separate from Rhea: neutral S7P/E4P and a DHAP dilithium salt C3H5Li2O6P are not merged into anions. The frozen neutral ATP/ADP/SBP forms and erroneous PfkB inclusion are explicit source conflicts. The original wholeZIP/member/root provenance is retained, with no live per-pathway download claim. [PathBank:SMP0002110] The Calvin-cycle and riboneogenesis condensation E4P+DHAP->SBP and subsequent SBP hydrolysis have different direction and energy chemistry. Classical PPP transaldolase uses S7P+GAP, while ADP-heptose formation isomerizes S7P. The ATP-dependent phosphorylation/cleavage pair is distinct from those routes and from the six-event PPi branch; shared metabolites and earlier research mentions do not merge the pathway definitions. Native PfkA sequence-based NAD-kinase prediction, antisense/production engineering, altered carbon-catabolite repression and enzyme allostery studies are neighboring enzyme contexts, not additional bypass reactions. FbaA ts8/h8, RNA/engineered substrate variants and broader physiological annotations likewise do not demonstrate more steps in this pathway. Physical substrate channeling discussed speculatively in older work is not a demonstrated multienzyme complex. Older unavailable primary bodies remain explicitly abstract/native-annotation evidence. [EcoCyc:6PFK-1-CPX; EcoCyc:FRUCBISALD-CLASSII; PMID:7872790]

Pathway type
carbohydrate metabolism
Organism scope

Read the source YAML

Pathway network

82 nodes · 67 asserted directed edges

Arrows show recorded subject → object relationships, not necessarily metabolic flow. Select a node for details or an arrow for evidence. Scroll, zoom or find a node to explore.

Pathway network: sedoheptulose bisphosphate bypass 82 nodes · 67 asserted directed edges. Every arrow links to its evidence table row; nodes link to their component details. Isolated declared components are retained. RHEA:31444 — part_of → MetaCyc:PWY0-1517; The exact native reaction-list includes RXN0-6541. The ATP-dependent bypass has two internal events; neighboring PPP and glycolysis links are interfaces.; Evidence: MetaCyc:PWY0-1517part of RHEA:30169 — part_of → MetaCyc:PWY0-1517; The exact native reaction-list includes SEDOBISALDOL-RXN. The ATP-dependent bypass has two internal events; neighboring PPP and glycolysis links are interfaces.; Evidence: MetaCyc:PWY0-1517part of CHEBI:57483 — consumes → RHEA:31444; RHEA:31444 substrates contains CHEBI:57483 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.; Evidence: RHEA:31444consumes CHEBI:30616 — consumes → RHEA:31444; RHEA:31444 substrates contains CHEBI:30616 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.; Evidence: RHEA:31444consumes RHEA:31444 — produces → CHEBI:58335; RHEA:31444 products contains CHEBI:58335 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.; Evidence: RHEA:31444produces RHEA:31444 — produces → CHEBI:456216; RHEA:31444 products contains CHEBI:456216 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.; Evidence: RHEA:31444produces RHEA:31444 — produces → CHEBI:15378; RHEA:31444 products contains CHEBI:15378 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.; Evidence: RHEA:31444produces CHEBI:58335 — consumes → RHEA:30169; RHEA:30169 substrates contains CHEBI:58335 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.; Evidence: RHEA:30169consumes RHEA:30169 — produces → CHEBI:16897; RHEA:30169 products contains CHEBI:16897 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.; Evidence: RHEA:30169produces RHEA:30169 — produces → CHEBI:57642; RHEA:30169 products contains CHEBI:57642 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.; Evidence: RHEA:30169produces RHEA:31444 — provides_input_for → RHEA:30169; The native ordering links S7P phosphorylation to SBP cleavage through shared SBP. This direct intermediate relation adds no TPI, transport or PPi-dependent event.; Evidence: MetaCyc:PWY0-1517provides input for EcoCyc:6PFK-1-CPX — catalyzes → RHEA:31444; The exact native enzyme slot identifies this catalytic assembly for the SBP-bypass activity. Attached direct-assay annotation cites PMID19756045; this reference mapping does not assert ordinary wild-type whole-pathway flux.; Evidence: EcoCyc:ENZRXN0-7407catalyzes EcoCyc:FRUCBISALD-CLASSII — catalyzes → RHEA:30169; The exact native enzyme slot identifies this catalytic assembly for the SBP-bypass activity. Attached direct-assay annotation cites PMID19756045; this reference mapping does not assert ordinary wild-type whole-pathway flux.; Evidence: EcoCyc:ENZRXN0-7406catalyzes EcoCyc:6PFK-1-CPX — has_part → UniProtKB:P0A796; The direct native component specifies 4 copies of 6PFK-1-MONOMER. Reference-chain membership does not imply that an isolated monomer performs the complete reaction.; Evidence: EcoCyc:6PFK-1-CPX, EcoCyc:6PFK-1-MONOMER, UniProtKB:P0A796has part EcoCyc:FRUCBISALD-CLASSII — has_part → UniProtKB:P0AB71; The direct native component specifies 2 copies of FRUCTBISALD-CLASSII-MONOMER. Reference-chain membership does not imply that an isolated monomer performs the complete reaction.; Evidence: EcoCyc:FRUCBISALD-CLASSII, EcoCyc:FRUCTBISALD-CLASSII-MONOMER, UniProtKB:P0AB71has part EcoCyc:6PFK-1-CPX — catalyzes → RHEA:31444; subject experimental construct: 2009 six-His ASKA PfkA preparation; assay clone is not asserted sequence-equal to MG1655 P0A796. 2 µM enzyme, S7P 5 mM, ATP 2 mM, potassium MOPS 50 mM, 37 °C, 1 h, n=5. This differs from the 2020 pET-28b/Rosetta preparation.; Evidence PMID:19756045: Methods specify purified six-His ASKA PfkA/FbaA, substrates and enzyme concentrations, ATP, potassium MOPS and the one-hour assay. (XPath /article/body/sec[4]/sec[11]/p[1] | /article/body/sec[4]/sec[11]/p[2]); PfkA with S7P and ATP produces candidate SBP; FbaA-only and no-enzyme controls do not. SBP was quantified with F1,6BP calibration because no authentic standard was available.; Evidence: PMID:19756045, PMID:19756045catalyzes EcoCyc:FRUCBISALD-CLASSII — catalyzes → RHEA:30169; subject experimental construct: 2009 six-His ASKA FbaA, 2 µM, assayed with PfkA-generated SBP from S7P 5 mM and ATP 2 mM in potassium MOPS, 37 °C, 1 h, n=5. This is not an isolated native monomer or an authenticated SBP-standard assay.; Evidence PMID:19756045: The primary methods specify the ASKA tagged preparations and conditions for the combined PfkA/FbaA assay. (XPath /article/body/sec[4]/sec[11]/p[1] | /article/body/sec[4]/sec[11]/p[2]); Direct two-enzyme evidence supports SBP cleavage to E4P and DHAP. The no-enzyme, PfkA-only, FbaA-only and F6P comparisons remain distinct; the model supplement and UniProt FUNCTION GAP wording do not replace measured DHAP.; Evidence: PMID:19756045catalyzes EcoCyc:6PFK-1-CPX — catalyzes → RHEA:31444; subject experimental construct: 2020 BW25113_3916 PfkA in pET-28b(+), DH5α cloning and Rosetta His-affinity expression. Coupled55 °C assay uses S7P Ba salt, Mg5 mM, ATP2 mM, ADP0.25 mM and rabbit aldolase/G3PDH/NADH; no added TPI. Distinct from F6P/2009 assays.; Evidence PMID:31871051: The primary methods identify E. coli PfkA cloning, pET-28b expression, His-affinity preparation and coupled kinase conditions; S7P is supplied as its Ba salt. (XPath /article/body/sec[5]/sec[3]/p[1] | /article/body/sec[5]/sec[3]/p[3] | /article/body/sec[5]/sec[7]/p[2] | /article/body/sec[5]/sec[7]/p[1]); Independent 2020 S7P kinase capacity under a 55 °C coupled assay. Coupling enzymes, NADH and suspected trace TPI are detection context, not new pathway events. Thesis Figure S4 presents both Michaelis–Menten and Hill fits; neither establishes physiological cooperativity of bypass flux.; Evidence: PMID:31871051catalyzes UniProtKB:P0A796 — located_in → GO:0005737; The issuing reference protein annotation places PfkA in the cytoplasm, retaining the annotation evidence role rather than claiming a new experiment.; Evidence: UniProtKB:P0A796located in UniProtKB:P0AB71 — located_in → GO:0005829; The exact cytosol GO annotation supplies IDA evidence and its cited localization studies. Location is not inferred from the protein SUBUNIT field.; Evidence: EcoCyc:FRUCTBISALD-CLASSII-MONOMERlocated in EcoCyc:6PFK-1-CPX — has_cofactor → CHEBI:18420; The reviewed reference annotation supports Mg2+ dependence, separate from ATP as a consumed core cosubstrate. The 2020 assay includes Mg but does not titrate an S7P-specific requirement.; Evidence: UniProtKB:P0A796has cofactor EcoCyc:FRUCBISALD-CLASSII — has_cofactor → CHEBI:29105; Class-II Zn dependence; the old per-dimer estimate and newer two-sites-per-subunit annotation differ. 2011 as-purified and Zn-loaded occupancies remain construct-specific context, not a universal fixed loading.; Evidence: UniProtKB:P0AB71, PMID:8436219has cofactor EcoCyc:FRUCBISALD-CLASSII — has_cofactor → CHEBI:48828; Alternative Co2+-containing FbaA activity is source-qualified. The 2011 assay found no effect of added Mn on its preparation; alternative cofactor substitution and additive activation are different experiments.; Evidence: EcoCyc:FRUCBISALD-CLASSIIhas cofactor EcoCyc:FRUCBISALD-CLASSII — has_cofactor → CHEBI:29033; Alternative Fe2+-containing FbaA activity is source-qualified. The 2011 assay found no effect of added Mn on its preparation; alternative cofactor substitution and additive activation are different experiments.; Evidence: EcoCyc:FRUCBISALD-CLASSIIhas cofactor EcoCyc:FRUCBISALD-CLASSII — has_cofactor → CHEBI:29035; Alternative Mn2+-containing FbaA activity is source-qualified. The 2011 assay found no effect of added Mn on its preparation; alternative cofactor substitution and additive activation are different experiments.; Evidence: EcoCyc:FRUCBISALD-CLASSIIhas cofactor CHEBI:58702 — inhibits → EcoCyc:6PFK-1-CPX; PEP regulation is established for canonical F6P-dependent PfkA activity. Transfer of its sign or magnitude to the ATP-dependent S7P bypass has not been directly demonstrated by these sources.; Evidence: EcoCyc:REG0-7473, UniProtKB:P0A796inhibits CHEBI:456216 — activates → EcoCyc:6PFK-1-CPX; ADP regulation is established for canonical F6P-dependent PfkA activity. Transfer of its sign or magnitude to the ATP-dependent S7P bypass has not been directly demonstrated by these sources.; Evidence: EcoCyc:REG0-7474, UniProtKB:P0A796activates CHEBI:58189 — activates → EcoCyc:6PFK-1-CPX; GDP regulation is established for canonical F6P-dependent PfkA activity. Transfer of its sign or magnitude to the ATP-dependent S7P bypass has not been directly demonstrated by these sources.; Evidence: EcoCyc:REG0-7475, UniProtKB:P0A796activates CHEBI:28938 — activates → EcoCyc:FRUCBISALD-CLASSII; Native canonical-activity ammonium effect. K+/ammonium evidence is an explicit personal-communication annotation; EDTA charge identity is the native source link. The unspecified reagent form and older Crookes preparation context are not silently converted into a new direct assay.; Evidence: EcoCyc:REG0-12168, EcoCyc:F16ALDOLASE-ENZRXN-CLASSIIactivates CHEBI:29103 — activates → EcoCyc:FRUCBISALD-CLASSII; Native canonical-activity potassium effect. K+/ammonium evidence is an explicit personal-communication annotation; EDTA charge identity is the native source link. The unspecified reagent form and older Crookes preparation context are not silently converted into a new direct assay.; Evidence: EcoCyc:REG0-12169, EcoCyc:F16ALDOLASE-ENZRXN-CLASSIIactivates CHEBI:64755 — inhibits → EcoCyc:FRUCBISALD-CLASSII; Native canonical-activity EDTA effect. K+/ammonium evidence is an explicit personal-communication annotation; EDTA charge identity is the native source link. The unspecified reagent form and older Crookes preparation context are not silently converted into a new direct assay.; Evidence: EcoCyc:REG0-8470, EcoCyc:F16ALDOLASE-ENZRXN-CLASSIIinhibits CHEBI:49786 — inhibits → EcoCyc:FRUCBISALD-CLASSII; object experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.; Evidence PMID:22014167: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay. (XPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]); Time- and concentration-dependent inhibition; Zn-site substitution is supported, not direct SBP kinetics. Calcium, Mg and Mn had no effect in the same comparison; those negatives do not refute activity of separately substituted metalloproteins.; Evidence: PMID:22014167inhibits CHEBI:29036 — inhibits → EcoCyc:FRUCBISALD-CLASSII; object experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.; Evidence PMID:22014167: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay. (XPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]); Substantial inhibition in vitro; the authors caution that cytoplasmic copper is mainly cuprous, so physiological Cu2+ regulation is not established. Calcium, Mg and Mn had no effect in the same comparison; those negatives do not refute activity of separately substituted metalloproteins.; Evidence: PMID:22014167inhibits CHEBI:29105 — activates → EcoCyc:FRUCBISALD-CLASSII; object experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.; Evidence PMID:22014167: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay. (XPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]); Slight activation at low added Zn; full loading requires the separate denaturation/metallation treatment. Calcium, Mg and Mn had no effect in the same comparison; those negatives do not refute activity of separately substituted metalloproteins.; Evidence: PMID:22014167activates CHEBI:29105 — inhibits → EcoCyc:FRUCBISALD-CLASSII; object experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.; Evidence PMID:22014167: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay. (XPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]); Very slight inhibition at higher added Zn; this does not negate the essential catalytic Zn role. Calcium, Mg and Mn had no effect in the same comparison; those negatives do not refute activity of separately substituted metalloproteins.; Evidence: PMID:22014167inhibits CHEBI:48828 — activates → EcoCyc:FRUCBISALD-CLASSII; object experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.; Evidence PMID:22014167: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay. (XPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]); Slight stimulation under this preparation/assay; alternative Co metalloprotein annotations are separate evidence. Calcium, Mg and Mn had no effect in the same comparison; those negatives do not refute activity of separately substituted metalloproteins.; Evidence: PMID:22014167activates CHEBI:64755 — inhibits → EcoCyc:FRUCBISALD-CLASSII; object experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.; Evidence PMID:22014167: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay. (XPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]); Purification of untagged pLEM1 FbaA was confirmed by sensitivity to100 µM EDTA; this is an independent preparation-specific chelator effect.; Evidence: PMID:22014167inhibits CHEBI:57595 — activates → EcoCyc:FRUCBISALD-CLASSII; object experimental construct: 2011 as-purified untagged MG1655/pLEM1 FbaA20 nM challenged with Ni2+16 µM, with His100 µM or GSH1 mM, aerobic25 °C. Effect is relative to the Ni-only condition; no direct ligand binding to FbaA or universal modifier effect is asserted.; Evidence PMID:22014167: Figure7A uses as-purified FbaA20 nM and Ni16 µM with His100 µM or reduced glutathione1 mM; the untagged purification is described separately. (XPath /collection/document/passage[50] | /collection/document/passage[117]); Conditional preservation of FbaA activity during Ni challenge. His is a Ni ligand; direct FbaA binding or an effect without Ni is not inferred. The selected physiological histidine form does not establish assay protonation state.; Evidence: PMID:22014167, EcoCyc:HISactivates CHEBI:57925 — inhibits → EcoCyc:FRUCBISALD-CLASSII; object experimental construct: 2011 as-purified untagged MG1655/pLEM1 FbaA20 nM challenged with Ni2+16 µM, with His100 µM or GSH1 mM, aerobic25 °C. Effect is relative to the Ni-only condition; no direct ligand binding to FbaA or universal modifier effect is asserted.; Evidence PMID:22014167: Figure7A uses as-purified FbaA20 nM and Ni16 µM with His100 µM or reduced glutathione1 mM; the untagged purification is described separately. (XPath /collection/document/passage[50] | /collection/document/passage[117]); Conditional sensitization in the Ni-containing assay, not generic glutathione inhibition of FbaA. The source specifies reduced glutathione; it does not measure the ligand protonation state or establish direct enzyme binding.; Evidence: PMID:22014167, EcoCyc:GLUTATHIONEinhibits CHEBI:30616 — activates → EcoCyc:FRUCBISALD-CLASSII; object experimental construct: 2019 ASKA His-tagged FbaA (>90% purity), TALON-purified after0.1 mM IPTG/16 h/37 °C. Canonical FBP1 mM assay at30 °C in Tris10 mM pH7.5/Mg1 mM; enzyme≈1 µM monomer equivalent and modifier5 mM; triplicate activity measurements.; Evidence PMID:31464375: Methods identify His-tagged ASKA preparations, purification, expression and the30 °C FBP activity assay; this is distinct from the2009 SBP assay and2011 untagged preparation. (XPath /article/body/sec[4]/sec[2]/sec[1]/p | /article/body/sec[4]/sec[2]/sec[6]/sec[2]/p); ATP activates the assayed canonical FBP cleavage, not directly measured SBP cleavage. ATP concentration is within the cited physiological range;3PG/PEP concentrations exceed it. Earlier3PG inhibition and1995 no-effect reports remain separate conflicting assay contexts.; Evidence: PMID:31464375, PMID:31464375activates CHEBI:58272 — activates → EcoCyc:FRUCBISALD-CLASSII; object experimental construct: 2019 ASKA His-tagged FbaA (>90% purity), TALON-purified after0.1 mM IPTG/16 h/37 °C. Canonical FBP1 mM assay at30 °C in Tris10 mM pH7.5/Mg1 mM; enzyme≈1 µM monomer equivalent and modifier5 mM; triplicate activity measurements.; Evidence PMID:31464375: Methods identify His-tagged ASKA preparations, purification, expression and the30 °C FBP activity assay; this is distinct from the2009 SBP assay and2011 untagged preparation. (XPath /article/body/sec[4]/sec[2]/sec[1]/p | /article/body/sec[4]/sec[2]/sec[6]/sec[2]/p); 3-phosphoglycerate activates the assayed canonical FBP cleavage, not directly measured SBP cleavage. ATP concentration is within the cited physiological range;3PG/PEP concentrations exceed it. Earlier3PG inhibition and1995 no-effect reports remain separate conflicting assay contexts.; Evidence: PMID:31464375, PMID:31464375activates CHEBI:58702 — activates → EcoCyc:FRUCBISALD-CLASSII; object experimental construct: 2019 ASKA His-tagged FbaA (>90% purity), TALON-purified after0.1 mM IPTG/16 h/37 °C. Canonical FBP1 mM assay at30 °C in Tris10 mM pH7.5/Mg1 mM; enzyme≈1 µM monomer equivalent and modifier5 mM; triplicate activity measurements.; Evidence PMID:31464375: Methods identify His-tagged ASKA preparations, purification, expression and the30 °C FBP activity assay; this is distinct from the2009 SBP assay and2011 untagged preparation. (XPath /article/body/sec[4]/sec[2]/sec[1]/p | /article/body/sec[4]/sec[2]/sec[6]/sec[2]/p); PEP activates the assayed canonical FBP cleavage, not directly measured SBP cleavage. ATP concentration is within the cited physiological range;3PG/PEP concentrations exceed it. Earlier3PG inhibition and1995 no-effect reports remain separate conflicting assay contexts.; Evidence: PMID:31464375, PMID:31464375activates EcoCyc:PC00061 — has_part → UniProtKB:P0ACP1; The native component identifies 4 copies of PD00521. This supports reference assembly composition, not occupancy or sequence identity of every tagged assay preparation.; Evidence: EcoCyc:PC00061, EcoCyc:PD00521has part EcoCyc:PC00004 — has_part → UniProtKB:P0ACJ8; The native component identifies 2 copies of PD00257. This supports reference assembly composition, not occupancy or sequence identity of every tagged assay preparation.; Evidence: EcoCyc:PC00004, EcoCyc:PD00257has part EcoCyc:CPLX-127 — has_part → EcoCyc:PC00061; The native component slot links this exact ligand-bound regulator to this component. No missing ligand coefficient is supplied by inference.; Evidence: EcoCyc:CPLX-127has part EcoCyc:CPLX-127 — has_part → CHEBI:138881; The native component slot links this exact ligand-bound regulator to this component. No missing ligand coefficient is supplied by inference.; Evidence: EcoCyc:CPLX-127, EcoCyc:FRU1Phas part EcoCyc:CPLX0-226 — has_part → EcoCyc:PC00004; The native component slot links this exact ligand-bound regulator to this component. No missing ligand coefficient is supplied by inference.; Evidence: EcoCyc:CPLX0-226has part EcoCyc:CPLX0-226 — has_part → CHEBI:58165; The native component slot links this exact ligand-bound regulator to this component. No missing ligand coefficient is supplied by inference.; Evidence: EcoCyc:CPLX0-226, EcoCyc:CAMPhas part EcoCyc:PC00061 — inhibits → Entrez:948412; subject experimental construct: 1996 six-His FruR/Cra in binding-site selection and pfkA analysis; source-described tetramer, not a sequenced untagged MG1655 control. Exact construct details are limited to the inspected abstract; native promoter/site joins provide separate gene-specific context.; Evidence PMID:8858581: The primary abstract specifies six-His FruR, asymmetric consensus/operator binding, tetramer context and negative pfkA regulation. (resultList.result[id='8858581'].abstractText); The native mode is negative for Cra regulation of the pfkA promoter. This and REG0-4838 represent the same BS785 biological-site context rather than two independent mechanisms.; Evidence: EcoCyc:REG0-15081, EcoCyc:TU0-45236, PMID:8858581, Entrez:948412inhibits EcoCyc:PC00061 — inhibits → Entrez:947415; Native operon-mediated fbaA repression through the epd promoter. REG0-5630 and REG0-15233 share the biological epd site context. The broader1996 FruR abstract supports the regulon, but is not used as a gene-specific quote absent from its text.; Evidence: EcoCyc:REG0-15233, EcoCyc:TU0-45273, Entrez:947415inhibits CHEBI:58674 — inhibits → EcoCyc:PC00061; object experimental construct: 2018 source-described E. coli Cra preparation in thermal-shift, microscale-thermophoresis and EMSA assays. Only the primary abstract was acquired: tag/cleavage/sequence details are unresolved. The native reference tetramer does not assert the exact assay material.; Evidence PMID:29923648: The abstract identifies thermal-shift/MST and EMSA assays on Cra, with F1P and FBP comparisons; full construct methods were not acquired. (resultList.result[id='29923648'].abstractText); Source-limited inhibition of Cra operator binding by generic F1P; assay anomer/protonation is not measured. Older FBP-effector discussions and the later negative result remain explicit. No FBP→Cra inhibition edge is inferred.; Evidence: PMID:29923648, EcoCyc:D-fructofuranose-1-phosphateinhibits EcoCyc:CPLX0-226 — activates → Entrez:947415; Positive native operon-associated expression effect. In the inspected1998 abstract, the glucose response is indirect; no direct fbaA-promoter activation or universal CRP sign is asserted. REG0-5629 is the same biological promoter context.; Evidence: EcoCyc:REG0-15234, EcoCyc:TU0-45273, PMID:9851989, Entrez:947415activates UniProtKB:P69786 — activates → Entrez:947415; Indirect glucose/PTS-associated operon expression context via PtsG. It is not a pathway-specific S7P transporter, direct fbaA DNA interaction or a crr/EIIA assignment.; Evidence: PMID:9851989, EcoCyc:TU0-45273, UniProtKB:P69786, Entrez:945651, Entrez:947415activates UniProtKB:P13445 — activates → Entrez:948412; subject experimental construct: 2009 His-tagged RpoS from pET28b+ in ER2566, combined with commercial RNAP core (core:sigma1:5) for pfkA-promoter transcription. The isolated reference sigma chain is not an autonomous polymerase; exact source construct and reconstituted system delimit this claim.; Evidence PMID:19838295: Methods distinguish purified tagged sigma-factor preparations and reconstitution with RNA polymerase core for in-vitro transcription. (XPath /article/body/sec[4]/sec[9]/p[2] | /article/body/sec[4]/sec[9]/p[3]); Reconstituted RNAP with RpoS supports transcription from the tested first pfkA promoter; sigma-dependent activity belongs to the assembled assay system.; Evidence: PMID:19838295, Entrez:948412activates UniProtKB:P00579 — activates → Entrez:948412; subject experimental construct: 2009 His-tagged RpoD from pET28b+ in ER2566, combined with commercial RNAP core (core:sigma1:5) for pfkA-promoter transcription. The isolated reference sigma chain is not an autonomous polymerase; exact source construct and reconstituted system delimit this claim.; Evidence PMID:19838295: Methods distinguish purified tagged sigma-factor preparations and reconstitution with RNA polymerase core for in-vitro transcription. (XPath /article/body/sec[4]/sec[9]/p[2] | /article/body/sec[4]/sec[9]/p[3]); Reconstituted RNAP with RpoD supports transcription from the tested first pfkA promoter; sigma-dependent activity belongs to the assembled assay system.; Evidence: PMID:19838295, Entrez:948412activates UniProtKB:P13445 — activates → Entrez:947415; subject experimental construct: 2009 JM101-derived PB11/PB12 ΔptsH ptsI crr backgrounds and rpoS derivatives during aerobic M9 glucose growth. The RpoS subject denotes an expression contrast, not purified binding or the BW25113 talAB bypass cohort.; Evidence PMID:19838295: The source compares JM101, PTS-deficient PB11/PB12 and their rpoS derivatives under specified glucose-growth conditions. (XPath /article/body/sec[4]/sec[1]/p); Condition-specific RpoS-associated fbaA expression, distinct from direct reconstituted pfkA transcription. Failure to find an immediate fbaA promoter here is not general promoter absence.; Evidence: PMID:19838295, Entrez:947415activates UniProtKB:P69913 — activates → Entrez:948412; subject experimental construct: 2016 isogenic csrA51 hypomorph versus source wild type, M9 glucose; attenuated CsrA, not a complete deletion. Subject is a reference anchor for expression/rescue inference. The abstract/native annotation does not identify a direct pfkA RNA-binding site.; Evidence PMID:26833659: The primary abstract compares a CsrA-attenuated strain to its wild type, with PfkA restoration/rescue; it does not specify a direct pfkA RNA-binding site. (resultList.result[id='26833659'].abstractText); Evidence EcoCyc:6PFK-1-CPX: The native comment explicitly identifies the csrA51 hypomorphic allele and M9 glucose context. (XPath /ptools-xml/Protein/comment); CsrA attenuation disrupts upper glycolysis; restoring PfkA activity suppresses glucose-phosphate stress and increases growth. This supports a positive expression contribution, not a new physical RNA-binding claim.; Evidence: PMID:26833659, EcoCyc:6PFK-1-CPX, Entrez:947176, Entrez:948412activates UniProtKB:P0ABJ1 — inhibits → Entrez:948412; subject experimental construct: 2011 BW25113 Keio cyoA deletion versus source wild type in aerobic continuous glucose culture: D0.2 h−1,37 °C,pH7,DO35–40%, C/N1.68 or8.42. Reference protein is an anchor for indirect knockout inference, not a tested purified active-state species.; Evidence PMID:21272324: Methods identify BW25113 Keio single deletions and the aerobic continuous-culture conditions; multiple network effects can mediate expression changes. (XPath /collection/document/passage[51]); Conditional transcript effect from a single-deletion comparison, not direct DNA binding or evidence of a universal regulatory sign. The Fnr contrast under oxygen does not imply the canonical anaerobic [4Fe-4S] active state. C/N-specific comparisons and network interpretations remain in source context.; Evidence: PMID:21272324, Entrez:945080, UniProtKB:P0ABJ1, Entrez:948412inhibits UniProtKB:P0ABK2 — inhibits → Entrez:948412; subject experimental construct: 2011 BW25113 Keio cydB deletion versus source wild type in aerobic continuous glucose culture: D0.2 h−1,37 °C,pH7,DO35–40%, C/N1.68 or8.42. Reference protein is an anchor for indirect knockout inference, not a tested purified active-state species.; Evidence PMID:21272324: Methods identify BW25113 Keio single deletions and the aerobic continuous-culture conditions; multiple network effects can mediate expression changes. (XPath /collection/document/passage[51]); Conditional transcript effect from a single-deletion comparison, not direct DNA binding or evidence of a universal regulatory sign. The Fnr contrast under oxygen does not imply the canonical anaerobic [4Fe-4S] active state. C/N-specific comparisons and network interpretations remain in source context.; Evidence: PMID:21272324, Entrez:945347, UniProtKB:P0ABK2, Entrez:948412inhibits UniProtKB:P0A9E5 — inhibits → Entrez:948412; subject experimental construct: 2011 BW25113 Keio fnr deletion versus source wild type in aerobic continuous glucose culture: D0.2 h−1,37 °C,pH7,DO35–40%, C/N1.68 or8.42. Reference protein is an anchor for indirect knockout inference, not a tested purified active-state species.; Evidence PMID:21272324: Methods identify BW25113 Keio single deletions and the aerobic continuous-culture conditions; multiple network effects can mediate expression changes. (XPath /collection/document/passage[51]); Conditional transcript effect from a single-deletion comparison, not direct DNA binding or evidence of a universal regulatory sign. The Fnr contrast under oxygen does not imply the canonical anaerobic [4Fe-4S] active state. C/N-specific comparisons and network interpretations remain in source context.; Evidence: PMID:21272324, Entrez:945908, UniProtKB:P0A9E5, Entrez:948412inhibits UniProtKB:P0A9A9 — inhibits → Entrez:948412; subject experimental construct: 2011 BW25113 Keio fur deletion versus source wild type in aerobic continuous glucose culture: D0.2 h−1,37 °C,pH7,DO35–40%, C/N1.68 or8.42. Reference protein is an anchor for indirect knockout inference, not a tested purified active-state species.; Evidence PMID:21272324: Methods identify BW25113 Keio single deletions and the aerobic continuous-culture conditions; multiple network effects can mediate expression changes. (XPath /collection/document/passage[51]); Conditional transcript effect from a single-deletion comparison, not direct DNA binding or evidence of a universal regulatory sign. The Fnr contrast under oxygen does not imply the canonical anaerobic [4Fe-4S] active state. C/N-specific comparisons and network interpretations remain in source context.; Evidence: PMID:21272324, Entrez:945295, UniProtKB:P0A9A9, Entrez:948412inhibits CHEBI:57634 — activates → EcoCyc:6PFK-1-CPX; Positive cooperative response to canonical F6P substrate; this does not establish that F6P activates S7P phosphorylation or imply a separate allosteric ligand mechanism.; Evidence: EcoCyc:REG0-7476, EcoCyc:FRUCTOSE-6Pactivates MetaCyc:PWY0-1517 — has_part → PathBank:SMP0121065; The exact frozen native bypass root attaches this named child. This is source structural membership, not an extra core reaction, transport or independently inferred causal direction.; Evidence: PathBank:SMP0002110has part MetaCyc:PWY0-1517 — has_part → PathBank:SMP0000807; The exact frozen native bypass root attaches this named child. This is source structural membership, not an extra core reaction, transport or independently inferred causal direction.; Evidence: PathBank:SMP0002110has part PathBank:SMP0121065 — has_part → PathBank:SMP0002110/Compound/PW_C000843; Unsigned structural participant context, using the exact native local compound. Native neutral S7P/E4P and dilithium DHAP remain distinct from the Rhea anions. The generic Interaction supplies no transport mechanism, regulatory sign or extra stoichiometric conversion.; Evidence: PathBank:SMP0002110has part PathBank:SMP0121065 — has_part → PathBank:SMP0002110/Compound/PW_C001019; Unsigned structural participant context, using the exact native local compound. Native neutral S7P/E4P and dilithium DHAP remain distinct from the Rhea anions. The generic Interaction supplies no transport mechanism, regulatory sign or extra stoichiometric conversion.; Evidence: PathBank:SMP0002110has part PathBank:SMP0000807 — has_part → PathBank:SMP0002110/Compound/PW_C042631; Unsigned structural participant context, using the exact native local compound. Native neutral S7P/E4P and dilithium DHAP remain distinct from the Rhea anions. The generic Interaction supplies no transport mechanism, regulatory sign or extra stoichiometric conversion.; Evidence: PathBank:SMP0002110has part sedoheptulose 7-phosphate(2-); CHEBI:57483; Declared type: small_molecule small molecule sedoheptulose 7-phosphate(2-) ATP(4-); CHEBI:30616; Declared type: small_molecule small molecule ATP(4-) sedoheptulose 1,7-bisphosphate(4-); CHEBI:58335; Declared type: small_molecule small molecule sedoheptulose 1,7-bisphosphate(4-) ADP(3-); CHEBI:456216; Declared type: small_molecule small molecule ADP(3-) hydron; CHEBI:15378; Declared type: small_molecule small molecule hydron D-erythrose 4-phosphate(2-); CHEBI:16897; Declared type: small_molecule small molecule D-erythrose 4-phosphate(2-) glycerone phosphate(2-); CHEBI:57642; Declared type: small_molecule small molecule glycerone phosphate(2-) magnesium(2+); CHEBI:18420; Declared type: cofactor cofactor magnesium(2+) zinc(2+); CHEBI:29105; Declared type: cofactor cofactor zinc(2+) cobalt(2+); CHEBI:48828; Declared type: cofactor cofactor cobalt(2+) iron(2+); CHEBI:29033; Declared type: cofactor cofactor iron(2+) manganese(2+); CHEBI:29035; Declared type: cofactor cofactor manganese(2+) nickel(2+); CHEBI:49786; Declared type: small_molecule small molecule nickel(2+) copper(2+); CHEBI:29036; Declared type: small_molecule small molecule copper(2+) calcium(2+); CHEBI:29108; Declared type: small_molecule small molecule calcium(2+) potassium(1+); CHEBI:29103; Declared type: small_molecule small molecule potassium(1+) ammonium; CHEBI:28938; Declared type: small_molecule small molecule ammonium EDTA(2-); CHEBI:64755; Declared type: small_molecule small molecule EDTA(2-) L-histidine zwitterion; CHEBI:57595; Declared type: small_molecule small molecule L-histidine zwitterion glutathionate(1-); CHEBI:57925; Declared type: small_molecule small molecule glutathionate(1-) 3-phosphonato-D-glycerate(3-); CHEBI:58272; Declared type: small_molecule small molecule 3-phosphonato-D- glycerate(3-) phosphonatoenolpyruvate; CHEBI:58702; Declared type: small_molecule small molecule phosphonatoenolpyruvate GDP(3-); CHEBI:58189; Declared type: small_molecule small molecule GDP(3-) 3',5'-cyclic AMP(1-); CHEBI:58165; Declared type: small_molecule small molecule 3',5'-cyclic AMP(1-) D-fructofuranose 1-phosphate(2-); CHEBI:58674; Declared type: small_molecule small molecule D-fructofuranose 1-phosphate(2-) beta-D-fructofuranose 1-phosphate(2-); CHEBI:138881; Declared type: small_molecule small molecule beta-D-fructofuranose 1-phosphate(2-) D-fructofuranose 1,6-bisphosphate(4-); CHEBI:49299; Declared type: small_molecule small molecule D-fructofuranose 1,6-bisphosphate(4-) ATP-dependent 6-phosphofructokinase isozyme 1; UniProtKB:P0A796; Declared type: protein protein ATP-dependent 6-phosphofructokinase isozyme 1 Fructose-bisphosphate aldolase class 2; UniProtKB:P0AB71; Declared type: protein protein Fructose-bisphosphate aldolase class 2 Catabolite repressor/activator; UniProtKB:P0ACP1; Declared type: protein protein Catabolite repressor/activator DNA-binding transcriptional dual regulator CRP; UniProtKB:P0ACJ8; Declared type: protein protein DNA-binding transcriptional dual regulator CRP RNA polymerase sigma factor RpoS; UniProtKB:P13445; Declared type: protein protein RNA polymerase sigma factor RpoS RNA polymerase sigma factor RpoD; UniProtKB:P00579; Declared type: protein protein RNA polymerase sigma factor RpoD Carbon storage regulator; UniProtKB:P69913; Declared type: protein protein Carbon storage regulator PTS system glucose-specific EIICB component; UniProtKB:P69786; Declared type: protein protein PTS system glucose-specific EIICB component Fumarate and nitrate reduction regulatory protein; UniProtKB:P0A9E5; Declared type: protein protein Fumarate and nitrate reduction regulatory protein Ferric uptake regulation protein; UniProtKB:P0A9A9; Declared type: protein protein Ferric uptake regulation protein Cytochrome bo(3) ubiquinol oxidase subunit 2; UniProtKB:P0ABJ1; Declared type: protein protein Cytochrome bo(3) ubiquinol oxidase subunit 2 Cytochrome bd-I ubiquinol oxidase subunit 2; UniProtKB:P0ABK2; Declared type: protein protein Cytochrome bd-I ubiquinol oxidase subunit 2 6-phosphofructokinase 1; EcoCyc:6PFK-1-CPX; Declared type: complex complex 6-phosphofructokinase 1 fructose-bisphosphate aldolase class II; EcoCyc:FRUCBISALD-CLASSII; Declared type: complex complex fructose-bisphosphate aldolase class II DNA-binding transcriptional dual regulator Cra; EcoCyc:PC00061; Declared type: complex complex DNA-binding transcriptional dual regulator Cra Cra-β-D-fructofuranose 1-phosphate; EcoCyc:CPLX-127; Declared type: complex complex Cra-β-D-fructofuranose 1-phosphate DNA-binding transcriptional dual regulator CRP; EcoCyc:PC00004; Declared type: complex complex DNA-binding transcriptional dual regulator CRP CRP-cyclic-AMP DNA-binding transcriptional dual regulator; EcoCyc:CPLX0-226; Declared type: complex complex CRP-cyclic-AMP DNA-binding transcriptional dual regulator pfkA; Entrez:948412; Declared type: gene gene pfkA fbaA; Entrez:947415; Declared type: gene gene fbaA cytoplasm; GO:0005737; Declared type: cellular_component cellular component cytoplasm cytosol; GO:0005829; Declared type: cellular_component cellular component cytosol D-Sedoheptulose 7-phosphate; PathBank:SMP0002110/Compound/PW_C000843; Declared type: small_molecule small molecule D-Sedoheptulose 7-phosphate D-Erythrose 4-phosphate; PathBank:SMP0002110/Compound/PW_C001019; Declared type: small_molecule small molecule D-Erythrose 4-phosphate Glycerone phosphate; PathBank:SMP0002110/Compound/PW_C042631; Declared type: small_molecule small molecule Glycerone phosphate beta-D-fructofuranose 6-phosphate(2-); CHEBI:57634; Declared type: small_molecule small molecule beta-D-fructofuranose 6-phosphate(2-) D-sedoheptulose 7-phosphate + ATP => D-sedoheptulose 1,7-bisphosphate + ADP + H(+); RHEA:31444; Declared type: molecular_activity; Source reaction direction: left_to_right molecular activity D-sedoheptulose 7-phosphate + ATP => D-sedoheptulose 1,7-bisphosphate + ADP + H(+) D-sedoheptulose 1,7-bisphosphate => D-erythrose 4-phosphate + dihydroxyacetone phosphate; RHEA:30169; Declared type: molecular_activity; Source reaction direction: right_to_left molecular activity D-sedoheptulose 1,7-bisphosphate => D-erythrose 4-phosphate + dihydroxyacetone phosphate Pentose Phosphate; PathBank:SMP0121065; Declared type: pathway pathway Pentose Phosphate Glycolysis and Pyruvate Dehydrogenase; PathBank:SMP0000807; Declared type: pathway pathway Glycolysis and Pyruvate Dehydrogenase sedoheptulose bisphosphate bypass; MetaCyc:PWY0-1517; Declared type: pathway pathway sedoheptulose bisphosphate bypass 6-phosphofructokinase 1; EcoCyc:6PFK-1-CPX; Declared type: complex; experimental construct: 2009 six-His ASKA PfkA preparation; assay clone is not asserted sequence-equal to MG1655 P0A796. 2 µM enzyme, S7P 5 mM, ATP 2 mM, potassium MOPS 50 mM, 37 °C, 1 h, n=5. This differs from the 2020 pET-28b/Rosetta preparation.; Evidence PMID:19756045: Methods specify purified six-His ASKA PfkA/FbaA, substrates and enzyme concentrations, ATP, potassium MOPS and the one-hour assay. (XPath /article/body/sec[4]/sec[11]/p[1] | /article/body/sec[4]/sec[11]/p[2]) experimental construct 6-phosphofructokinase 1 [experimental construct: 2009 six-His ASKA PfkA preparation; assay clone is not asserted sequence-equal to MG1655 P0A796. 2…] fructose-bisphosphate aldolase class II; EcoCyc:FRUCBISALD-CLASSII; Declared type: complex; experimental construct: 2009 six-His ASKA FbaA, 2 µM, assayed with PfkA-generated SBP from S7P 5 mM and ATP 2 mM in potassium MOPS, 37 °C, 1 h, n=5. This is not an isolated native monomer or an authenticated SBP-standard assay.; Evidence PMID:19756045: The primary methods specify the ASKA tagged preparations and conditions for the combined PfkA/FbaA assay. (XPath /article/body/sec[4]/sec[11]/p[1] | /article/body/sec[4]/sec[11]/p[2]) experimental construct fructose-bisphosphate aldolase class II [experimental construct: 2009 six-His ASKA FbaA, 2 µM, assayed with PfkA- generated SBP from S7P 5 mM and ATP 2 mM in…] 6-phosphofructokinase 1; EcoCyc:6PFK-1-CPX; Declared type: complex; experimental construct: 2020 BW25113_3916 PfkA in pET-28b(+), DH5α cloning and Rosetta His-affinity expression. Coupled55 °C assay uses S7P Ba salt, Mg5 mM, ATP2 mM, ADP0.25 mM and rabbit aldolase/G3PDH/NADH; no added TPI. Distinct from F6P/2009 assays.; Evidence PMID:31871051: The primary methods identify E. coli PfkA cloning, pET-28b expression, His-affinity preparation and coupled kinase conditions; S7P is supplied as its Ba salt. (XPath /article/body/sec[5]/sec[3]/p[1] | /article/body/sec[5]/sec[3]/p[3] | /article/body/sec[5]/sec[7]/p[2] | /article/body/sec[5]/sec[7]/p[1]) experimental construct 6-phosphofructokinase 1 [experimental construct: 2020 BW25113_3916 PfkA in pET-28b(+), DH5α cloning and Rosetta His-affinity expression. Coupled55…] fructose-bisphosphate aldolase class II; EcoCyc:FRUCBISALD-CLASSII; Declared type: complex; experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.; Evidence PMID:22014167: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay. (XPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]) experimental construct fructose-bisphosphate aldolase class II [experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled…] fructose-bisphosphate aldolase class II; EcoCyc:FRUCBISALD-CLASSII; Declared type: complex; experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.; Evidence PMID:22014167: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay. (XPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]) experimental construct fructose-bisphosphate aldolase class II [experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled…] fructose-bisphosphate aldolase class II; EcoCyc:FRUCBISALD-CLASSII; Declared type: complex; experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.; Evidence PMID:22014167: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay. (XPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]) experimental construct fructose-bisphosphate aldolase class II [experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled…] fructose-bisphosphate aldolase class II; EcoCyc:FRUCBISALD-CLASSII; Declared type: complex; experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.; Evidence PMID:22014167: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay. (XPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]) experimental construct fructose-bisphosphate aldolase class II [experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled…] fructose-bisphosphate aldolase class II; EcoCyc:FRUCBISALD-CLASSII; Declared type: complex; experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.; Evidence PMID:22014167: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay. (XPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]) experimental construct fructose-bisphosphate aldolase class II [experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled…] fructose-bisphosphate aldolase class II; EcoCyc:FRUCBISALD-CLASSII; Declared type: complex; experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.; Evidence PMID:22014167: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay. (XPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]) experimental construct fructose-bisphosphate aldolase class II [experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled…] fructose-bisphosphate aldolase class II; EcoCyc:FRUCBISALD-CLASSII; Declared type: complex; experimental construct: 2011 as-purified untagged MG1655/pLEM1 FbaA20 nM challenged with Ni2+16 µM, with His100 µM or GSH1 mM, aerobic25 °C. Effect is relative to the Ni-only condition; no direct ligand binding to FbaA or universal modifier effect is asserted.; Evidence PMID:22014167: Figure7A uses as-purified FbaA20 nM and Ni16 µM with His100 µM or reduced glutathione1 mM; the untagged purification is described separately. (XPath /collection/document/passage[50] | /collection/document/passage[117]) experimental construct fructose-bisphosphate aldolase class II [experimental construct: 2011 as-purified untagged MG1655/pLEM1 FbaA20 nM challenged with Ni2+16 µM, with His100 µM or GSH1…] fructose-bisphosphate aldolase class II; EcoCyc:FRUCBISALD-CLASSII; Declared type: complex; experimental construct: 2011 as-purified untagged MG1655/pLEM1 FbaA20 nM challenged with Ni2+16 µM, with His100 µM or GSH1 mM, aerobic25 °C. Effect is relative to the Ni-only condition; no direct ligand binding to FbaA or universal modifier effect is asserted.; Evidence PMID:22014167: Figure7A uses as-purified FbaA20 nM and Ni16 µM with His100 µM or reduced glutathione1 mM; the untagged purification is described separately. (XPath /collection/document/passage[50] | /collection/document/passage[117]) experimental construct fructose-bisphosphate aldolase class II [experimental construct: 2011 as-purified untagged MG1655/pLEM1 FbaA20 nM challenged with Ni2+16 µM, with His100 µM or GSH1…] fructose-bisphosphate aldolase class II; EcoCyc:FRUCBISALD-CLASSII; Declared type: complex; experimental construct: 2019 ASKA His-tagged FbaA (>90% purity), TALON-purified after0.1 mM IPTG/16 h/37 °C. Canonical FBP1 mM assay at30 °C in Tris10 mM pH7.5/Mg1 mM; enzyme≈1 µM monomer equivalent and modifier5 mM; triplicate activity measurements.; Evidence PMID:31464375: Methods identify His-tagged ASKA preparations, purification, expression and the30 °C FBP activity assay; this is distinct from the2009 SBP assay and2011 untagged preparation. (XPath /article/body/sec[4]/sec[2]/sec[1]/p | /article/body/sec[4]/sec[2]/sec[6]/sec[2]/p) experimental construct fructose-bisphosphate aldolase class II [experimental construct: 2019 ASKA His-tagged FbaA (>90% purity), TALON- purified after0.1 mM IPTG/16 h/37 °C. Canonical FBP1…] fructose-bisphosphate aldolase class II; EcoCyc:FRUCBISALD-CLASSII; Declared type: complex; experimental construct: 2019 ASKA His-tagged FbaA (>90% purity), TALON-purified after0.1 mM IPTG/16 h/37 °C. Canonical FBP1 mM assay at30 °C in Tris10 mM pH7.5/Mg1 mM; enzyme≈1 µM monomer equivalent and modifier5 mM; triplicate activity measurements.; Evidence PMID:31464375: Methods identify His-tagged ASKA preparations, purification, expression and the30 °C FBP activity assay; this is distinct from the2009 SBP assay and2011 untagged preparation. (XPath /article/body/sec[4]/sec[2]/sec[1]/p | /article/body/sec[4]/sec[2]/sec[6]/sec[2]/p) experimental construct fructose-bisphosphate aldolase class II [experimental construct: 2019 ASKA His-tagged FbaA (>90% purity), TALON- purified after0.1 mM IPTG/16 h/37 °C. Canonical FBP1…] fructose-bisphosphate aldolase class II; EcoCyc:FRUCBISALD-CLASSII; Declared type: complex; experimental construct: 2019 ASKA His-tagged FbaA (>90% purity), TALON-purified after0.1 mM IPTG/16 h/37 °C. Canonical FBP1 mM assay at30 °C in Tris10 mM pH7.5/Mg1 mM; enzyme≈1 µM monomer equivalent and modifier5 mM; triplicate activity measurements.; Evidence PMID:31464375: Methods identify His-tagged ASKA preparations, purification, expression and the30 °C FBP activity assay; this is distinct from the2009 SBP assay and2011 untagged preparation. (XPath /article/body/sec[4]/sec[2]/sec[1]/p | /article/body/sec[4]/sec[2]/sec[6]/sec[2]/p) experimental construct fructose-bisphosphate aldolase class II [experimental construct: 2019 ASKA His-tagged FbaA (>90% purity), TALON- purified after0.1 mM IPTG/16 h/37 °C. Canonical FBP1…] DNA-binding transcriptional dual regulator Cra; EcoCyc:PC00061; Declared type: complex; experimental construct: 1996 six-His FruR/Cra in binding-site selection and pfkA analysis; source-described tetramer, not a sequenced untagged MG1655 control. Exact construct details are limited to the inspected abstract; native promoter/site joins provide separate gene-specific context.; Evidence PMID:8858581: The primary abstract specifies six-His FruR, asymmetric consensus/operator binding, tetramer context and negative pfkA regulation. (resultList.result[id='8858581'].abstractText) experimental construct DNA-binding transcriptional dual regulator Cra [experimental construct: 1996 six-His FruR/Cra in binding-site selection and pfkA analysis; source- described tetramer, not a…] DNA-binding transcriptional dual regulator Cra; EcoCyc:PC00061; Declared type: complex; experimental construct: 2018 source-described E. coli Cra preparation in thermal-shift, microscale-thermophoresis and EMSA assays. Only the primary abstract was acquired: tag/cleavage/sequence details are unresolved. The native reference tetramer does not assert the exact assay material.; Evidence PMID:29923648: The abstract identifies thermal-shift/MST and EMSA assays on Cra, with F1P and FBP comparisons; full construct methods were not acquired. (resultList.result[id='29923648'].abstractText) experimental construct DNA-binding transcriptional dual regulator Cra [experimental construct: 2018 source-described E. coli Cra preparation in thermal-shift, microscale- thermophoresis and EMSA…] RNA polymerase sigma factor RpoS; UniProtKB:P13445; Declared type: protein; experimental construct: 2009 His-tagged RpoS from pET28b+ in ER2566, combined with commercial RNAP core (core:sigma1:5) for pfkA-promoter transcription. The isolated reference sigma chain is not an autonomous polymerase; exact source construct and reconstituted system delimit this claim.; Evidence PMID:19838295: Methods distinguish purified tagged sigma-factor preparations and reconstitution with RNA polymerase core for in-vitro transcription. (XPath /article/body/sec[4]/sec[9]/p[2] | /article/body/sec[4]/sec[9]/p[3]) experimental construct RNA polymerase sigma factor RpoS [experimental construct: 2009 His-tagged RpoS from pET28b+ in ER2566, combined with commercial RNAP core (core:sigma1:5) for…] RNA polymerase sigma factor RpoD; UniProtKB:P00579; Declared type: protein; experimental construct: 2009 His-tagged RpoD from pET28b+ in ER2566, combined with commercial RNAP core (core:sigma1:5) for pfkA-promoter transcription. The isolated reference sigma chain is not an autonomous polymerase; exact source construct and reconstituted system delimit this claim.; Evidence PMID:19838295: Methods distinguish purified tagged sigma-factor preparations and reconstitution with RNA polymerase core for in-vitro transcription. (XPath /article/body/sec[4]/sec[9]/p[2] | /article/body/sec[4]/sec[9]/p[3]) experimental construct RNA polymerase sigma factor RpoD [experimental construct: 2009 His-tagged RpoD from pET28b+ in ER2566, combined with commercial RNAP core (core:sigma1:5) for…] RNA polymerase sigma factor RpoS; UniProtKB:P13445; Declared type: protein; experimental construct: 2009 JM101-derived PB11/PB12 ΔptsH ptsI crr backgrounds and rpoS derivatives during aerobic M9 glucose growth. The RpoS subject denotes an expression contrast, not purified binding or the BW25113 talAB bypass cohort.; Evidence PMID:19838295: The source compares JM101, PTS-deficient PB11/PB12 and their rpoS derivatives under specified glucose-growth conditions. (XPath /article/body/sec[4]/sec[1]/p) experimental construct RNA polymerase sigma factor RpoS [experimental construct: 2009 JM101-derived PB11/PB12 ΔptsH ptsI crr backgrounds and rpoS derivatives during aerobic M9…] Carbon storage regulator; UniProtKB:P69913; Declared type: protein; experimental construct: 2016 isogenic csrA51 hypomorph versus source wild type, M9 glucose; attenuated CsrA, not a complete deletion. Subject is a reference anchor for expression/rescue inference. The abstract/native annotation does not identify a direct pfkA RNA-binding site.; Evidence PMID:26833659: The primary abstract compares a CsrA-attenuated strain to its wild type, with PfkA restoration/rescue; it does not specify a direct pfkA RNA-binding site. (resultList.result[id='26833659'].abstractText); Evidence EcoCyc:6PFK-1-CPX: The native comment explicitly identifies the csrA51 hypomorphic allele and M9 glucose context. (XPath /ptools-xml/Protein/comment) experimental construct Carbon storage regulator [experimental construct: 2016 isogenic csrA51 hypomorph versus source wild type, M9 glucose; attenuated CsrA, not a complete…] Cytochrome bo(3) ubiquinol oxidase subunit 2; UniProtKB:P0ABJ1; Declared type: protein; experimental construct: 2011 BW25113 Keio cyoA deletion versus source wild type in aerobic continuous glucose culture: D0.2 h−1,37 °C,pH7,DO35–40%, C/N1.68 or8.42. Reference protein is an anchor for indirect knockout inference, not a tested purified active-state species.; Evidence PMID:21272324: Methods identify BW25113 Keio single deletions and the aerobic continuous-culture conditions; multiple network effects can mediate expression changes. (XPath /collection/document/passage[51]) experimental construct Cytochrome bo(3) ubiquinol oxidase subunit 2 [experimental construct: 2011 BW25113 Keio cyoA deletion versus source wild type in aerobic continuous glucose culture: D0.2…] Cytochrome bd-I ubiquinol oxidase subunit 2; UniProtKB:P0ABK2; Declared type: protein; experimental construct: 2011 BW25113 Keio cydB deletion versus source wild type in aerobic continuous glucose culture: D0.2 h−1,37 °C,pH7,DO35–40%, C/N1.68 or8.42. Reference protein is an anchor for indirect knockout inference, not a tested purified active-state species.; Evidence PMID:21272324: Methods identify BW25113 Keio single deletions and the aerobic continuous-culture conditions; multiple network effects can mediate expression changes. (XPath /collection/document/passage[51]) experimental construct Cytochrome bd-I ubiquinol oxidase subunit 2 [experimental construct: 2011 BW25113 Keio cydB deletion versus source wild type in aerobic continuous glucose culture: D0.2…] Fumarate and nitrate reduction regulatory protein; UniProtKB:P0A9E5; Declared type: protein; experimental construct: 2011 BW25113 Keio fnr deletion versus source wild type in aerobic continuous glucose culture: D0.2 h−1,37 °C,pH7,DO35–40%, C/N1.68 or8.42. Reference protein is an anchor for indirect knockout inference, not a tested purified active-state species.; Evidence PMID:21272324: Methods identify BW25113 Keio single deletions and the aerobic continuous-culture conditions; multiple network effects can mediate expression changes. (XPath /collection/document/passage[51]) experimental construct Fumarate and nitrate reduction regulatory protein [experimental construct: 2011 BW25113 Keio fnr deletion versus source wild type in aerobic continuous glucose culture: D0.2…] Ferric uptake regulation protein; UniProtKB:P0A9A9; Declared type: protein; experimental construct: 2011 BW25113 Keio fur deletion versus source wild type in aerobic continuous glucose culture: D0.2 h−1,37 °C,pH7,DO35–40%, C/N1.68 or8.42. Reference protein is an anchor for indirect knockout inference, not a tested purified active-state species.; Evidence PMID:21272324: Methods identify BW25113 Keio single deletions and the aerobic continuous-culture conditions; multiple network effects can mediate expression changes. (XPath /collection/document/passage[51]) experimental construct Ferric uptake regulation protein [experimental construct: 2011 BW25113 Keio fur deletion versus source wild type in aerobic continuous glucose culture: D0.2…]

Components and activities

Declared biological components and source reaction directions
NodeKind or roleSource direction
Escherichia coli
NCBITaxon:562
taxon
Escherichia coli K-12
NCBITaxon:83333
taxon
Escherichia coli str. K-12 substr. MG1655
NCBITaxon:511145
taxon
Escherichia coli BW25113
NCBITaxon:679895
taxon
sedoheptulose 7-phosphate(2-)
CHEBI:57483
small molecule
ATP(4-)
CHEBI:30616
small molecule
sedoheptulose 1,7-bisphosphate(4-)
CHEBI:58335
small molecule
ADP(3-)
CHEBI:456216
small molecule
hydron
CHEBI:15378
small molecule
D-erythrose 4-phosphate(2-)
CHEBI:16897
small molecule
glycerone phosphate(2-)
CHEBI:57642
small molecule
magnesium(2+)
CHEBI:18420
cofactor
zinc(2+)
CHEBI:29105
cofactor
cobalt(2+)
CHEBI:48828
cofactor
iron(2+)
CHEBI:29033
cofactor
manganese(2+)
CHEBI:29035
cofactor
nickel(2+)
CHEBI:49786
small molecule
copper(2+)
CHEBI:29036
small molecule
calcium(2+)
CHEBI:29108
small molecule
potassium(1+)
CHEBI:29103
small molecule
ammonium
CHEBI:28938
small molecule
EDTA(2-)
CHEBI:64755
small molecule
L-histidine zwitterion
CHEBI:57595
small molecule
glutathionate(1-)
CHEBI:57925
small molecule
3-phosphonato-D-glycerate(3-)
CHEBI:58272
small molecule
phosphonatoenolpyruvate
CHEBI:58702
small molecule
GDP(3-)
CHEBI:58189
small molecule
3',5'-cyclic AMP(1-)
CHEBI:58165
small molecule
D-fructofuranose 1-phosphate(2-)
CHEBI:58674
small molecule
beta-D-fructofuranose 1-phosphate(2-)
CHEBI:138881
small molecule
D-fructofuranose 1,6-bisphosphate(4-)
CHEBI:49299
small molecule
ATP-dependent 6-phosphofructokinase isozyme 1
UniProtKB:P0A796
protein
Fructose-bisphosphate aldolase class 2
UniProtKB:P0AB71
protein
Catabolite repressor/activator
UniProtKB:P0ACP1
protein
DNA-binding transcriptional dual regulator CRP
UniProtKB:P0ACJ8
protein
RNA polymerase sigma factor RpoS
UniProtKB:P13445
protein
RNA polymerase sigma factor RpoD
UniProtKB:P00579
protein
Carbon storage regulator
UniProtKB:P69913
protein
PTS system glucose-specific EIICB component
UniProtKB:P69786
protein
Fumarate and nitrate reduction regulatory protein
UniProtKB:P0A9E5
protein
Ferric uptake regulation protein
UniProtKB:P0A9A9
protein
Cytochrome bo(3) ubiquinol oxidase subunit 2
UniProtKB:P0ABJ1
protein
Cytochrome bd-I ubiquinol oxidase subunit 2
UniProtKB:P0ABK2
protein
6-phosphofructokinase 1
EcoCyc:6PFK-1-CPX
complex
fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII
complex
DNA-binding transcriptional dual regulator Cra
EcoCyc:PC00061
complex
Cra-β-D-fructofuranose 1-phosphate
EcoCyc:CPLX-127
complex
DNA-binding transcriptional dual regulator CRP
EcoCyc:PC00004
complex
CRP-cyclic-AMP DNA-binding transcriptional dual regulator
EcoCyc:CPLX0-226
complex
pfkA
Entrez:948412
gene
fbaA
Entrez:947415
gene
cytoplasm
GO:0005737
cellular component
cytosol
GO:0005829
cellular component
D-Sedoheptulose 7-phosphate
PathBank:SMP0002110/Compound/PW_C000843
small molecule
D-Erythrose 4-phosphate
PathBank:SMP0002110/Compound/PW_C001019
small molecule
Glycerone phosphate
PathBank:SMP0002110/Compound/PW_C042631
small molecule
beta-D-fructofuranose 6-phosphate(2-)
CHEBI:57634
small molecule
D-sedoheptulose 7-phosphate + ATP => D-sedoheptulose 1,7-bisphosphate + ADP + H(+)
RHEA:31444
molecular activityleft to right
D-sedoheptulose 1,7-bisphosphate => D-erythrose 4-phosphate + dihydroxyacetone phosphate
RHEA:30169
molecular activityright to left
Pentose Phosphate
PathBank:SMP0121065
pathway
Glycolysis and Pyruvate Dehydrogenase
PathBank:SMP0000807
pathway

Mechanistic edges

Mechanistic edges and their cited evidence
SubjectPredicate and descriptionObjectEvidence
D-sedoheptulose 7-phosphate + ATP => D-sedoheptulose 1,7-bisphosphate + ADP + H(+)
RHEA:31444
part_of

The exact native reaction-list includes RXN0-6541. The ATP-dependent bypass has two internal events; neighboring PPP and glycolysis links are interfaces.

MetaCyc:PWY0-1517
  • MetaCyc:PWY0-1517

    Source assertion: The exact native reaction-list includes RXN0-6541. The ATP-dependent bypass has two internal events; neighboring PPP and glycolysis links are interfaces.

    Source locationXPath /ptools-xml/Pathway/reaction-list/Reaction[@frameid="RXN0-6541"]
D-sedoheptulose 1,7-bisphosphate => D-erythrose 4-phosphate + dihydroxyacetone phosphate
RHEA:30169
part_of

The exact native reaction-list includes SEDOBISALDOL-RXN. The ATP-dependent bypass has two internal events; neighboring PPP and glycolysis links are interfaces.

MetaCyc:PWY0-1517
  • MetaCyc:PWY0-1517

    Source assertion: The exact native reaction-list includes SEDOBISALDOL-RXN. The ATP-dependent bypass has two internal events; neighboring PPP and glycolysis links are interfaces.

    Source locationXPath /ptools-xml/Pathway/reaction-list/Reaction[@frameid="SEDOBISALDOL-RXN"]
sedoheptulose 7-phosphate(2-)
CHEBI:57483
consumes

RHEA:31444 substrates contains CHEBI:57483 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

D-sedoheptulose 7-phosphate + ATP => D-sedoheptulose 1,7-bisphosphate + ADP + H(+)
RHEA:31444
  • RHEA:31444

    Source assertion: RHEA:31444 substrates contains CHEBI:57483 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

    Source locationRHEA:31444 rh:substrates; http://rdf.rhea-db.org/Participant_31443_compound_3830 rh:compound http://rdf.rhea-db.org/Compound_3830; rh:contains1
ATP(4-)
CHEBI:30616
consumes

RHEA:31444 substrates contains CHEBI:30616 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

D-sedoheptulose 7-phosphate + ATP => D-sedoheptulose 1,7-bisphosphate + ADP + H(+)
RHEA:31444
  • RHEA:31444

    Source assertion: RHEA:31444 substrates contains CHEBI:30616 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

    Source locationRHEA:31444 rh:substrates; http://rdf.rhea-db.org/Participant_31443_compound_6372 rh:compound http://rdf.rhea-db.org/Compound_6372; rh:contains1
D-sedoheptulose 7-phosphate + ATP => D-sedoheptulose 1,7-bisphosphate + ADP + H(+)
RHEA:31444
produces

RHEA:31444 products contains CHEBI:58335 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

sedoheptulose 1,7-bisphosphate(4-)
CHEBI:58335
  • RHEA:31444

    Source assertion: RHEA:31444 products contains CHEBI:58335 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

    Source locationRHEA:31444 rh:products; http://rdf.rhea-db.org/Participant_31443_compound_2479 rh:compound http://rdf.rhea-db.org/Compound_2479; rh:contains1
D-sedoheptulose 7-phosphate + ATP => D-sedoheptulose 1,7-bisphosphate + ADP + H(+)
RHEA:31444
produces

RHEA:31444 products contains CHEBI:456216 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

ADP(3-)
CHEBI:456216
  • RHEA:31444

    Source assertion: RHEA:31444 products contains CHEBI:456216 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

    Source locationRHEA:31444 rh:products; http://rdf.rhea-db.org/Participant_31443_compound_2710 rh:compound http://rdf.rhea-db.org/Compound_2710; rh:contains1
D-sedoheptulose 7-phosphate + ATP => D-sedoheptulose 1,7-bisphosphate + ADP + H(+)
RHEA:31444
produces

RHEA:31444 products contains CHEBI:15378 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

hydron
CHEBI:15378
  • RHEA:31444

    Source assertion: RHEA:31444 products contains CHEBI:15378 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

    Source locationRHEA:31444 rh:products; http://rdf.rhea-db.org/Participant_31443_compound_3249 rh:compound http://rdf.rhea-db.org/Compound_3249; rh:contains1
sedoheptulose 1,7-bisphosphate(4-)
CHEBI:58335
consumes

RHEA:30169 substrates contains CHEBI:58335 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

D-sedoheptulose 1,7-bisphosphate => D-erythrose 4-phosphate + dihydroxyacetone phosphate
RHEA:30169
  • RHEA:30169

    Source assertion: RHEA:30169 substrates contains CHEBI:58335 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

    Source locationRHEA:30169 rh:substrates; http://rdf.rhea-db.org/Participant_30167_compound_2479 rh:compound http://rdf.rhea-db.org/Compound_2479; rh:contains1
D-sedoheptulose 1,7-bisphosphate => D-erythrose 4-phosphate + dihydroxyacetone phosphate
RHEA:30169
produces

RHEA:30169 products contains CHEBI:16897 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

D-erythrose 4-phosphate(2-)
CHEBI:16897
  • RHEA:30169

    Source assertion: RHEA:30169 products contains CHEBI:16897 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

    Source locationRHEA:30169 rh:products; http://rdf.rhea-db.org/Participant_30167_compound_5282 rh:compound http://rdf.rhea-db.org/Compound_5282; rh:contains1
D-sedoheptulose 1,7-bisphosphate => D-erythrose 4-phosphate + dihydroxyacetone phosphate
RHEA:30169
produces

RHEA:30169 products contains CHEBI:57642 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

glycerone phosphate(2-)
CHEBI:57642
  • RHEA:30169

    Source assertion: RHEA:30169 products contains CHEBI:57642 at coefficient 1. Exact native directional participants and containsN multiplicity define this side; generic S7P is not replaced by an alpha-pyranose child.

    Source locationRHEA:30169 rh:products; http://rdf.rhea-db.org/Participant_30167_compound_4255 rh:compound http://rdf.rhea-db.org/Compound_4255; rh:contains1
D-sedoheptulose 7-phosphate + ATP => D-sedoheptulose 1,7-bisphosphate + ADP + H(+)
RHEA:31444
provides_input_for

The native ordering links S7P phosphorylation to SBP cleavage through shared SBP. This direct intermediate relation adds no TPI, transport or PPi-dependent event.

D-sedoheptulose 1,7-bisphosphate => D-erythrose 4-phosphate + dihydroxyacetone phosphate
RHEA:30169
  • MetaCyc:PWY0-1517

    Source assertion: The native ordering links S7P phosphorylation to SBP cleavage through shared SBP. This direct intermediate relation adds no TPI, transport or PPi-dependent event.

    Source locationXPath /ptools-xml/Pathway/reaction-ordering
6-phosphofructokinase 1
EcoCyc:6PFK-1-CPX
catalyzes

The exact native enzyme slot identifies this catalytic assembly for the SBP-bypass activity. Attached direct-assay annotation cites PMID19756045; this reference mapping does not assert ordinary wild-type whole-pathway flux.

D-sedoheptulose 7-phosphate + ATP => D-sedoheptulose 1,7-bisphosphate + ADP + H(+)
RHEA:31444
  • EcoCyc:ENZRXN0-7407

    Source assertion: The exact native enzyme slot identifies this catalytic assembly for the SBP-bypass activity. Attached direct-assay annotation cites PMID19756045; this reference mapping does not assert ordinary wild-type whole-pathway flux.

    Source locationXPath /ptools-xml/Enzymatic-Reaction/enzyme | /ptools-xml/Enzymatic-Reaction/reaction
fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII
catalyzes

The exact native enzyme slot identifies this catalytic assembly for the SBP-bypass activity. Attached direct-assay annotation cites PMID19756045; this reference mapping does not assert ordinary wild-type whole-pathway flux.

D-sedoheptulose 1,7-bisphosphate => D-erythrose 4-phosphate + dihydroxyacetone phosphate
RHEA:30169
  • EcoCyc:ENZRXN0-7406

    Source assertion: The exact native enzyme slot identifies this catalytic assembly for the SBP-bypass activity. Attached direct-assay annotation cites PMID19756045; this reference mapping does not assert ordinary wild-type whole-pathway flux.

    Source locationXPath /ptools-xml/Enzymatic-Reaction/enzyme | /ptools-xml/Enzymatic-Reaction/reaction
6-phosphofructokinase 1
EcoCyc:6PFK-1-CPX
has_part

The direct native component specifies 4 copies of 6PFK-1-MONOMER. Reference-chain membership does not imply that an isolated monomer performs the complete reaction.

ATP-dependent 6-phosphofructokinase isozyme 1
UniProtKB:P0A796
  • EcoCyc:6PFK-1-CPX

    Source assertion: The direct native component specifies 4 copies of 6PFK-1-MONOMER. Reference-chain membership does not imply that an isolated monomer performs the complete reaction.

    Source locationXPath /ptools-xml/Protein/component
  • EcoCyc:6PFK-1-MONOMER

    Source assertion: The monomer unification cross-reference identifies UniProtKB:P0A796. It does not prove sequence equality of each historical or tagged assay preparation.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT" and dblink-oid="P0A796"]
  • UniProtKB:P0A796

    Source assertion: The reviewed native annotation supports the homotetramer.

    Source locationentry[primaryAccession='P0A796'].comments[commentType='SUBUNIT']
fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII
has_part

The direct native component specifies 2 copies of FRUCTBISALD-CLASSII-MONOMER. Reference-chain membership does not imply that an isolated monomer performs the complete reaction.

Fructose-bisphosphate aldolase class 2
UniProtKB:P0AB71
  • EcoCyc:FRUCBISALD-CLASSII

    Source assertion: The direct native component specifies 2 copies of FRUCTBISALD-CLASSII-MONOMER. Reference-chain membership does not imply that an isolated monomer performs the complete reaction.

    Source locationXPath /ptools-xml/Protein/component
  • EcoCyc:FRUCTBISALD-CLASSII-MONOMER

    Source assertion: The monomer unification cross-reference identifies UniProtKB:P0AB71. It does not prove sequence equality of each historical or tagged assay preparation.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT" and dblink-oid="P0AB71"]
  • UniProtKB:P0AB71

    Source assertion: The reviewed native annotation supports the homodimer.

    Source locationentry[primaryAccession='P0AB71'].comments[commentType='SUBUNIT']
6-phosphofructokinase 1
EcoCyc:6PFK-1-CPX

experimental construct: 2009 six-His ASKA PfkA preparation; assay clone is not asserted sequence-equal to MG1655 P0A796. 2 µM enzyme, S7P 5 mM, ATP 2 mM, potassium MOPS 50 mM, 37 °C, 1 h, n=5. This differs from the 2020 pET-28b/Rosetta preparation.

Qualification evidence
  • PMID:19756045

    Source assertion: Methods specify purified six-His ASKA PfkA/FbaA, substrates and enzyme concentrations, ATP, potassium MOPS and the one-hour assay.

    Source locationXPath /article/body/sec[4]/sec[11]/p[1] | /article/body/sec[4]/sec[11]/p[2]
catalyzes

PfkA with S7P and ATP produces candidate SBP; FbaA-only and no-enzyme controls do not. SBP was quantified with F1,6BP calibration because no authentic standard was available.

D-sedoheptulose 7-phosphate + ATP => D-sedoheptulose 1,7-bisphosphate + ADP + H(+)
RHEA:31444
  • PMID:19756045

    Source assertion: PfkA with S7P and ATP produces candidate SBP; FbaA-only and no-enzyme controls do not. SBP was quantified with F1,6BP calibration because no authentic standard was available.

    Source locationXPath /article/body/sec[2]/sec[6]/table-wrap | /article/body/sec[2]/sec[4]/p[1] | /article/body/sec[4]/sec[11]/p[2]
  • PMID:19756045

    Source assertion: The primary combined-enzyme assay identifies the two-step route. Results use m/z369.0 while Methods use367.0; the internal discrepancy remains explicit.

    Source locationXPath /article/body/sec[2]/sec[6]/p | /article/body/sec[4]/sec[11]/p[2]
fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII

experimental construct: 2009 six-His ASKA FbaA, 2 µM, assayed with PfkA-generated SBP from S7P 5 mM and ATP 2 mM in potassium MOPS, 37 °C, 1 h, n=5. This is not an isolated native monomer or an authenticated SBP-standard assay.

Qualification evidence
  • PMID:19756045

    Source assertion: The primary methods specify the ASKA tagged preparations and conditions for the combined PfkA/FbaA assay.

    Source locationXPath /article/body/sec[4]/sec[11]/p[1] | /article/body/sec[4]/sec[11]/p[2]
catalyzes

Direct two-enzyme evidence supports SBP cleavage to E4P and DHAP. The no-enzyme, PfkA-only, FbaA-only and F6P comparisons remain distinct; the model supplement and UniProt FUNCTION GAP wording do not replace measured DHAP.

D-sedoheptulose 1,7-bisphosphate => D-erythrose 4-phosphate + dihydroxyacetone phosphate
RHEA:30169
  • PMID:19756045

    Source assertion: Adding FbaA to PfkA/S7P/ATP yields measured E4P and DHAP; PfkA alone yields candidate SBP without those products. The five separate controls constrain the interpretation.

    Source locationXPath /article/body/sec[2]/sec[6]/table-wrap
6-phosphofructokinase 1
EcoCyc:6PFK-1-CPX

experimental construct: 2020 BW25113_3916 PfkA in pET-28b(+), DH5α cloning and Rosetta His-affinity expression. Coupled55 °C assay uses S7P Ba salt, Mg5 mM, ATP2 mM, ADP0.25 mM and rabbit aldolase/G3PDH/NADH; no added TPI. Distinct from F6P/2009 assays.

Qualification evidence
  • PMID:31871051

    Source assertion: The primary methods identify E. coli PfkA cloning, pET-28b expression, His-affinity preparation and coupled kinase conditions; S7P is supplied as its Ba salt.

    Source locationXPath /article/body/sec[5]/sec[3]/p[1] | /article/body/sec[5]/sec[3]/p[3] | /article/body/sec[5]/sec[7]/p[2] | /article/body/sec[5]/sec[7]/p[1]
catalyzes

Independent 2020 S7P kinase capacity under a 55 °C coupled assay. Coupling enzymes, NADH and suspected trace TPI are detection context, not new pathway events. Thesis Figure S4 presents both Michaelis–Menten and Hill fits; neither establishes physiological cooperativity of bypass flux.

D-sedoheptulose 7-phosphate + ATP => D-sedoheptulose 1,7-bisphosphate + ADP + H(+)
RHEA:31444
  • PMID:31871051

    Source assertion: The E. coli PfkA S7P comparison reports apparent Km2.5 mM and kcat0.25 s−1, versus F6P0.065 mM and1.2 s−1; the S7P catalytic-efficiency entry is retained as reported, not recalculated.

    Source locationXPath /article/body/sec[2]/sec[2]/table-wrap | /article/body/sec[2]/sec[2]/p[5]
ATP-dependent 6-phosphofructokinase isozyme 1
UniProtKB:P0A796
located_in

The issuing reference protein annotation places PfkA in the cytoplasm, retaining the annotation evidence role rather than claiming a new experiment.

cytoplasm
GO:0005737
  • UniProtKB:P0A796

    Source assertion: The issuing reference protein annotation places PfkA in the cytoplasm, retaining the annotation evidence role rather than claiming a new experiment.

    Source locationentry[primaryAccession='P0A796'].comments[commentType='SUBCELLULAR LOCATION']
Fructose-bisphosphate aldolase class 2
UniProtKB:P0AB71
located_in

The exact cytosol GO annotation supplies IDA evidence and its cited localization studies. Location is not inferred from the protein SUBUNIT field.

cytosol
GO:0005829
  • EcoCyc:FRUCTBISALD-CLASSII-MONOMER

    Source assertion: The exact cytosol GO annotation supplies IDA evidence and its cited localization studies. Location is not inferred from the protein SUBUNIT field.

    Source locationXPath /ptools-xml/Protein/has-go-term[GO-Term[@frameid="GO:0005829"]]
6-phosphofructokinase 1
EcoCyc:6PFK-1-CPX
has_cofactor

The reviewed reference annotation supports Mg2+ dependence, separate from ATP as a consumed core cosubstrate. The 2020 assay includes Mg but does not titrate an S7P-specific requirement.

magnesium(2+)
CHEBI:18420
  • UniProtKB:P0A796

    Source assertion: The reviewed reference annotation supports Mg2+ dependence, separate from ATP as a consumed core cosubstrate. The 2020 assay includes Mg but does not titrate an S7P-specific requirement.

    Source locationentry[primaryAccession='P0A796'].comments[commentType='COFACTOR']
fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII
has_cofactor

Class-II Zn dependence; the old per-dimer estimate and newer two-sites-per-subunit annotation differ. 2011 as-purified and Zn-loaded occupancies remain construct-specific context, not a universal fixed loading.

zinc(2+)
CHEBI:29105
  • UniProtKB:P0AB71

    Source assertion: The issuing annotation gives catalytic and structural Zn sites, two Zn per subunit. Site capacity is not equal to solution occupancy in every purified preparation.

    Source locationentry[primaryAccession='P0AB71'].comments[commentType='COFACTOR']
  • PMID:8436219

    Source assertion: The older abstract reports two Zn per enzyme dimer; this is retained as a preparation/source discrepancy, not silently changed to the newer per-subunit capacity.

    Source locationresultList.result[id='8436219'].abstractText
fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII
has_cofactor

Alternative Co2+-containing FbaA activity is source-qualified. The 2011 assay found no effect of added Mn on its preparation; alternative cofactor substitution and additive activation are different experiments.

cobalt(2+)
CHEBI:48828
  • EcoCyc:FRUCBISALD-CLASSII

    Source assertion: The native annotation reports active Co2+ metalloprotein alternatives to Zn. This is older biochemical annotation, not a claim that adding this ion stimulates every holoenzyme preparation.

    Source locationXPath /ptools-xml/Protein/comment
fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII
has_cofactor

Alternative Fe2+-containing FbaA activity is source-qualified. The 2011 assay found no effect of added Mn on its preparation; alternative cofactor substitution and additive activation are different experiments.

iron(2+)
CHEBI:29033
  • EcoCyc:FRUCBISALD-CLASSII

    Source assertion: The native annotation reports active Fe2+ metalloprotein alternatives to Zn. This is older biochemical annotation, not a claim that adding this ion stimulates every holoenzyme preparation.

    Source locationXPath /ptools-xml/Protein/comment
fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII
has_cofactor

Alternative Mn2+-containing FbaA activity is source-qualified. The 2011 assay found no effect of added Mn on its preparation; alternative cofactor substitution and additive activation are different experiments.

manganese(2+)
CHEBI:29035
  • EcoCyc:FRUCBISALD-CLASSII

    Source assertion: The native annotation reports active Mn2+ metalloprotein alternatives to Zn. This is older biochemical annotation, not a claim that adding this ion stimulates every holoenzyme preparation.

    Source locationXPath /ptools-xml/Protein/comment
phosphonatoenolpyruvate
CHEBI:58702
inhibits

PEP regulation is established for canonical F6P-dependent PfkA activity. Transfer of its sign or magnitude to the ATP-dependent S7P bypass has not been directly demonstrated by these sources.

6-phosphofructokinase 1
EcoCyc:6PFK-1-CPX
  • EcoCyc:REG0-7473

    Source assertion: The native regulation assigns PEP a negative effect on 6PFRUCTPHOS-ENZRXN, the canonical F6P reaction. This is not a directly measured effect on S7P turnover.

    Source locationXPath /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/mode
  • UniProtKB:P0A796

    Source assertion: The reviewed reference annotation reports allosteric PEP inhibition and ADP/GDP activation of phosphofructokinase; source reaction scope is retained.

    Source locationentry[primaryAccession='P0A796'].comments[commentType='ACTIVITY REGULATION']
ADP(3-)
CHEBI:456216
activates

ADP regulation is established for canonical F6P-dependent PfkA activity. Transfer of its sign or magnitude to the ATP-dependent S7P bypass has not been directly demonstrated by these sources.

6-phosphofructokinase 1
EcoCyc:6PFK-1-CPX
  • EcoCyc:REG0-7474

    Source assertion: The native regulation assigns ADP a positive effect on 6PFRUCTPHOS-ENZRXN, the canonical F6P reaction. This is not a directly measured effect on S7P turnover.

    Source locationXPath /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/mode
  • UniProtKB:P0A796

    Source assertion: The reviewed reference annotation reports allosteric PEP inhibition and ADP/GDP activation of phosphofructokinase; source reaction scope is retained.

    Source locationentry[primaryAccession='P0A796'].comments[commentType='ACTIVITY REGULATION']
GDP(3-)
CHEBI:58189
activates

GDP regulation is established for canonical F6P-dependent PfkA activity. Transfer of its sign or magnitude to the ATP-dependent S7P bypass has not been directly demonstrated by these sources.

6-phosphofructokinase 1
EcoCyc:6PFK-1-CPX
  • EcoCyc:REG0-7475

    Source assertion: The native regulation assigns GDP a positive effect on 6PFRUCTPHOS-ENZRXN, the canonical F6P reaction. This is not a directly measured effect on S7P turnover.

    Source locationXPath /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/mode
  • UniProtKB:P0A796

    Source assertion: The reviewed reference annotation reports allosteric PEP inhibition and ADP/GDP activation of phosphofructokinase; source reaction scope is retained.

    Source locationentry[primaryAccession='P0A796'].comments[commentType='ACTIVITY REGULATION']
ammonium
CHEBI:28938
activates

Native canonical-activity ammonium effect. K+/ammonium evidence is an explicit personal-communication annotation; EDTA charge identity is the native source link. The unspecified reagent form and older Crookes preparation context are not silently converted into a new direct assay.

fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII
  • EcoCyc:REG0-12168

    Source assertion: The native regulation assigns ammonium a positive effect on F16ALDOLASE-ENZRXN-CLASSII. It concerns canonical FBP cleavage, not a measured SBP-turnover response.

    Source locationXPath /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/mode
  • EcoCyc:F16ALDOLASE-ENZRXN-CLASSII

    Source assertion: The native enzyme comment supplies assay/annotation context; K and ammonium activation is attributed to personal communication cited in1996. Older biochemical preparations are not automatically the current MG1655 reference.

    Source locationXPath /ptools-xml/Enzymatic-Reaction/comment
potassium(1+)
CHEBI:29103
activates

Native canonical-activity potassium effect. K+/ammonium evidence is an explicit personal-communication annotation; EDTA charge identity is the native source link. The unspecified reagent form and older Crookes preparation context are not silently converted into a new direct assay.

fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII
  • EcoCyc:REG0-12169

    Source assertion: The native regulation assigns potassium a positive effect on F16ALDOLASE-ENZRXN-CLASSII. It concerns canonical FBP cleavage, not a measured SBP-turnover response.

    Source locationXPath /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/mode
  • EcoCyc:F16ALDOLASE-ENZRXN-CLASSII

    Source assertion: The native enzyme comment supplies assay/annotation context; K and ammonium activation is attributed to personal communication cited in1996. Older biochemical preparations are not automatically the current MG1655 reference.

    Source locationXPath /ptools-xml/Enzymatic-Reaction/comment
EDTA(2-)
CHEBI:64755
inhibits

Native canonical-activity EDTA effect. K+/ammonium evidence is an explicit personal-communication annotation; EDTA charge identity is the native source link. The unspecified reagent form and older Crookes preparation context are not silently converted into a new direct assay.

fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII
  • EcoCyc:REG0-8470

    Source assertion: The native regulation assigns EDTA a negative effect on F16ALDOLASE-ENZRXN-CLASSII. It concerns canonical FBP cleavage, not a measured SBP-turnover response.

    Source locationXPath /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/mode
  • EcoCyc:F16ALDOLASE-ENZRXN-CLASSII

    Source assertion: The native enzyme comment supplies assay/annotation context; K and ammonium activation is attributed to personal communication cited in1996. Older biochemical preparations are not automatically the current MG1655 reference.

    Source locationXPath /ptools-xml/Enzymatic-Reaction/comment
nickel(2+)
CHEBI:49786
inhibits

Time- and concentration-dependent inhibition; Zn-site substitution is supported, not direct SBP kinetics. Calcium, Mg and Mn had no effect in the same comparison; those negatives do not refute activity of separately substituted metalloproteins.

fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII

experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.

Qualification evidence
  • PMID:22014167

    Source assertion: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay.

    Source locationXPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]
  • PMID:22014167

    Source assertion: The primary Results/Discussion describe Ni2+ with this sign under the purified canonical FbaA assay. Time- and concentration-dependent inhibition; Zn-site substitution is supported, not direct SBP kinetics.

    Source locationXPath /collection/document/passage[21] | /collection/document/passage[29]
copper(2+)
CHEBI:29036
inhibits

Substantial inhibition in vitro; the authors caution that cytoplasmic copper is mainly cuprous, so physiological Cu2+ regulation is not established. Calcium, Mg and Mn had no effect in the same comparison; those negatives do not refute activity of separately substituted metalloproteins.

fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII

experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.

Qualification evidence
  • PMID:22014167

    Source assertion: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay.

    Source locationXPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]
  • PMID:22014167

    Source assertion: The primary Results/Discussion describe Cu2+ with this sign under the purified canonical FbaA assay. Substantial inhibition in vitro; the authors caution that cytoplasmic copper is mainly cuprous, so physiological Cu2+ regulation is not established.

    Source locationXPath /collection/document/passage[21] | /collection/document/passage[29]
zinc(2+)
CHEBI:29105
activates

Slight activation at low added Zn; full loading requires the separate denaturation/metallation treatment. Calcium, Mg and Mn had no effect in the same comparison; those negatives do not refute activity of separately substituted metalloproteins.

fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII

experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.

Qualification evidence
  • PMID:22014167

    Source assertion: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay.

    Source locationXPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]
  • PMID:22014167

    Source assertion: The primary Results/Discussion describe low added Zn2+ with this sign under the purified canonical FbaA assay. Slight activation at low added Zn; full loading requires the separate denaturation/metallation treatment.

    Source locationXPath /collection/document/passage[21] | /collection/document/passage[29]
zinc(2+)
CHEBI:29105
inhibits

Very slight inhibition at higher added Zn; this does not negate the essential catalytic Zn role. Calcium, Mg and Mn had no effect in the same comparison; those negatives do not refute activity of separately substituted metalloproteins.

fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII

experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.

Qualification evidence
  • PMID:22014167

    Source assertion: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay.

    Source locationXPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]
  • PMID:22014167

    Source assertion: The primary Results/Discussion describe higher added Zn2+ with this sign under the purified canonical FbaA assay. Very slight inhibition at higher added Zn; this does not negate the essential catalytic Zn role.

    Source locationXPath /collection/document/passage[21] | /collection/document/passage[29]
cobalt(2+)
CHEBI:48828
activates

Slight stimulation under this preparation/assay; alternative Co metalloprotein annotations are separate evidence. Calcium, Mg and Mn had no effect in the same comparison; those negatives do not refute activity of separately substituted metalloproteins.

fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII

experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.

Qualification evidence
  • PMID:22014167

    Source assertion: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay.

    Source locationXPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]
  • PMID:22014167

    Source assertion: The primary Results/Discussion describe Co2+ with this sign under the purified canonical FbaA assay. Slight stimulation under this preparation/assay; alternative Co metalloprotein annotations are separate evidence.

    Source locationXPath /collection/document/passage[21] | /collection/document/passage[29]
EDTA(2-)
CHEBI:64755
inhibits

Purification of untagged pLEM1 FbaA was confirmed by sensitivity to100 µM EDTA; this is an independent preparation-specific chelator effect.

fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII

experimental construct: 2011 untagged FbaA purified from MG1655/pLEM1 (pWKS30), ≥70% purity; canonical FBP coupled activity. In-vitro challenge: 50 mM Tris-HCl pH7.5, aerobic25 °C. Separate pLEM5 His6 WT/mutant controls are not pooled into this preparation.

Qualification evidence
  • PMID:22014167

    Source assertion: Methods distinguish untagged pLEM1 purification from His-tagged pLEM5 WT/mutants, and specify the aerobic Tris-buffer challenge assay.

    Source locationXPath /collection/document/passage[40] | /collection/document/passage[50] | /collection/document/passage[52]
  • PMID:22014167

    Source assertion: Purification of untagged pLEM1 FbaA was confirmed by sensitivity to100 µM EDTA; this is an independent preparation-specific chelator effect.

    Source locationXPath /collection/document/passage[50]
L-histidine zwitterion
CHEBI:57595
activates

Conditional preservation of FbaA activity during Ni challenge. His is a Ni ligand; direct FbaA binding or an effect without Ni is not inferred. The selected physiological histidine form does not establish assay protonation state.

fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII

experimental construct: 2011 as-purified untagged MG1655/pLEM1 FbaA20 nM challenged with Ni2+16 µM, with His100 µM or GSH1 mM, aerobic25 °C. Effect is relative to the Ni-only condition; no direct ligand binding to FbaA or universal modifier effect is asserted.

Qualification evidence
  • PMID:22014167

    Source assertion: Figure7A uses as-purified FbaA20 nM and Ni16 µM with His100 µM or reduced glutathione1 mM; the untagged purification is described separately.

    Source locationXPath /collection/document/passage[50] | /collection/document/passage[117]
  • PMID:22014167

    Source assertion: Histidine protects Ni-challenged FbaA: about20% activity loss versus70% without histidine. The positive sign is conditional protection against Ni, not direct activation of untreated FbaA.

    Source locationXPath /collection/document/passage[25] | /collection/document/passage[117]
  • EcoCyc:HIS

    Source assertion: The native reference compound formula, charge, InChI and ChEBI link support this selected identity. Its CML SMILES is inconsistent and not used. The primary assay does not measure a unique reagent protonation state.

    Source locationXPath /ptools-xml/Compound/common-name | /ptools-xml/Compound/dblink[dblink-db="CHEBI"] | /ptools-xml/Compound/cml | /ptools-xml/Compound/inchi
glutathionate(1-)
CHEBI:57925
inhibits

Conditional sensitization in the Ni-containing assay, not generic glutathione inhibition of FbaA. The source specifies reduced glutathione; it does not measure the ligand protonation state or establish direct enzyme binding.

fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII

experimental construct: 2011 as-purified untagged MG1655/pLEM1 FbaA20 nM challenged with Ni2+16 µM, with His100 µM or GSH1 mM, aerobic25 °C. Effect is relative to the Ni-only condition; no direct ligand binding to FbaA or universal modifier effect is asserted.

Qualification evidence
  • PMID:22014167

    Source assertion: Figure7A uses as-purified FbaA20 nM and Ni16 µM with His100 µM or reduced glutathione1 mM; the untagged purification is described separately.

    Source locationXPath /collection/document/passage[50] | /collection/document/passage[117]
  • PMID:22014167

    Source assertion: Reduced glutathione enhances Ni-dependent FbaA inhibition. The rcnA/gshA comparison supports a cellular contribution; the proposed delivery mechanism is not uniquely established.

    Source locationXPath /collection/document/passage[25] | /collection/document/passage[117]
  • EcoCyc:GLUTATHIONE

    Source assertion: The native reference compound formula, charge, InChI and ChEBI link support this selected identity. Its CML SMILES is inconsistent and not used. The primary assay does not measure a unique reagent protonation state.

    Source locationXPath /ptools-xml/Compound/common-name | /ptools-xml/Compound/dblink[dblink-db="CHEBI"] | /ptools-xml/Compound/cml | /ptools-xml/Compound/inchi
ATP(4-)
CHEBI:30616
activates

ATP activates the assayed canonical FBP cleavage, not directly measured SBP cleavage. ATP concentration is within the cited physiological range;3PG/PEP concentrations exceed it. Earlier3PG inhibition and1995 no-effect reports remain separate conflicting assay contexts.

fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII

experimental construct: 2019 ASKA His-tagged FbaA (>90% purity), TALON-purified after0.1 mM IPTG/16 h/37 °C. Canonical FBP1 mM assay at30 °C in Tris10 mM pH7.5/Mg1 mM; enzyme≈1 µM monomer equivalent and modifier5 mM; triplicate activity measurements.

Qualification evidence
  • PMID:31464375

    Source assertion: Methods identify His-tagged ASKA preparations, purification, expression and the30 °C FBP activity assay; this is distinct from the2009 SBP assay and2011 untagged preparation.

    Source locationXPath /article/body/sec[4]/sec[2]/sec[1]/p | /article/body/sec[4]/sec[2]/sec[6]/sec[2]/p
  • PMID:31464375

    Source assertion: The purified-enzyme assay reports activation by ATP. Hypoxanthine and IMP show no effect in the same assay; NMR binding alone was not used to assign these signs.

    Source locationXPath /article/body/sec[2]/sec[4]/p
  • PMID:31464375

    Source assertion: The assay uses FBP1 mM and modifiers5 mM, with MS calibration for combined DHAP/GAP and triplicate activities; hypoxanthine is3.22 mM.

    Source locationXPath /article/body/sec[4]/sec[2]/sec[6]/sec[2]/p
3-phosphonato-D-glycerate(3-)
CHEBI:58272
activates

3-phosphoglycerate activates the assayed canonical FBP cleavage, not directly measured SBP cleavage. ATP concentration is within the cited physiological range;3PG/PEP concentrations exceed it. Earlier3PG inhibition and1995 no-effect reports remain separate conflicting assay contexts.

fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII

experimental construct: 2019 ASKA His-tagged FbaA (>90% purity), TALON-purified after0.1 mM IPTG/16 h/37 °C. Canonical FBP1 mM assay at30 °C in Tris10 mM pH7.5/Mg1 mM; enzyme≈1 µM monomer equivalent and modifier5 mM; triplicate activity measurements.

Qualification evidence
  • PMID:31464375

    Source assertion: Methods identify His-tagged ASKA preparations, purification, expression and the30 °C FBP activity assay; this is distinct from the2009 SBP assay and2011 untagged preparation.

    Source locationXPath /article/body/sec[4]/sec[2]/sec[1]/p | /article/body/sec[4]/sec[2]/sec[6]/sec[2]/p
  • PMID:31464375

    Source assertion: The purified-enzyme assay reports activation by 3-phosphoglycerate. Hypoxanthine and IMP show no effect in the same assay; NMR binding alone was not used to assign these signs.

    Source locationXPath /article/body/sec[2]/sec[4]/p
  • PMID:31464375

    Source assertion: The assay uses FBP1 mM and modifiers5 mM, with MS calibration for combined DHAP/GAP and triplicate activities; hypoxanthine is3.22 mM.

    Source locationXPath /article/body/sec[4]/sec[2]/sec[6]/sec[2]/p
phosphonatoenolpyruvate
CHEBI:58702
activates

PEP activates the assayed canonical FBP cleavage, not directly measured SBP cleavage. ATP concentration is within the cited physiological range;3PG/PEP concentrations exceed it. Earlier3PG inhibition and1995 no-effect reports remain separate conflicting assay contexts.

fructose-bisphosphate aldolase class II
EcoCyc:FRUCBISALD-CLASSII

experimental construct: 2019 ASKA His-tagged FbaA (>90% purity), TALON-purified after0.1 mM IPTG/16 h/37 °C. Canonical FBP1 mM assay at30 °C in Tris10 mM pH7.5/Mg1 mM; enzyme≈1 µM monomer equivalent and modifier5 mM; triplicate activity measurements.

Qualification evidence
  • PMID:31464375

    Source assertion: Methods identify His-tagged ASKA preparations, purification, expression and the30 °C FBP activity assay; this is distinct from the2009 SBP assay and2011 untagged preparation.

    Source locationXPath /article/body/sec[4]/sec[2]/sec[1]/p | /article/body/sec[4]/sec[2]/sec[6]/sec[2]/p
  • PMID:31464375

    Source assertion: The purified-enzyme assay reports activation by PEP. Hypoxanthine and IMP show no effect in the same assay; NMR binding alone was not used to assign these signs.

    Source locationXPath /article/body/sec[2]/sec[4]/p
  • PMID:31464375

    Source assertion: The assay uses FBP1 mM and modifiers5 mM, with MS calibration for combined DHAP/GAP and triplicate activities; hypoxanthine is3.22 mM.

    Source locationXPath /article/body/sec[4]/sec[2]/sec[6]/sec[2]/p
DNA-binding transcriptional dual regulator Cra
EcoCyc:PC00061
has_part

The native component identifies 4 copies of PD00521. This supports reference assembly composition, not occupancy or sequence identity of every tagged assay preparation.

Catabolite repressor/activator
UniProtKB:P0ACP1
  • EcoCyc:PC00061

    Source assertion: The native component identifies 4 copies of PD00521. This supports reference assembly composition, not occupancy or sequence identity of every tagged assay preparation.

    Source locationXPath /ptools-xml/Protein/component
  • EcoCyc:PD00521

    Source assertion: The exact native chain unification identifies UniProtKB:P0ACP1.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT"]
DNA-binding transcriptional dual regulator CRP
EcoCyc:PC00004
has_part

The native component identifies 2 copies of PD00257. This supports reference assembly composition, not occupancy or sequence identity of every tagged assay preparation.

DNA-binding transcriptional dual regulator CRP
UniProtKB:P0ACJ8
  • EcoCyc:PC00004

    Source assertion: The native component identifies 2 copies of PD00257. This supports reference assembly composition, not occupancy or sequence identity of every tagged assay preparation.

    Source locationXPath /ptools-xml/Protein/component
  • EcoCyc:PD00257

    Source assertion: The exact native chain unification identifies UniProtKB:P0ACJ8.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT"]
Cra-β-D-fructofuranose 1-phosphate
EcoCyc:CPLX-127
has_part

The native component slot links this exact ligand-bound regulator to this component. No missing ligand coefficient is supplied by inference.

DNA-binding transcriptional dual regulator Cra
EcoCyc:PC00061
  • EcoCyc:CPLX-127

    Source assertion: The native component slot links this exact ligand-bound regulator to this component. No missing ligand coefficient is supplied by inference.

    Source locationXPath /ptools-xml/Protein/component
Cra-β-D-fructofuranose 1-phosphate
EcoCyc:CPLX-127
has_part

The native component slot links this exact ligand-bound regulator to this component. No missing ligand coefficient is supplied by inference.

beta-D-fructofuranose 1-phosphate(2-)
CHEBI:138881
  • EcoCyc:CPLX-127

    Source assertion: The native component slot links this exact ligand-bound regulator to this component. No missing ligand coefficient is supplied by inference.

    Source locationXPath /ptools-xml/Protein/component
  • EcoCyc:FRU1P

    Source assertion: The native compound cross-reference grounds the exact ChEBI species used for this assembly component; a generic assay effector is not silently assigned its anomer.

    Source locationXPath /ptools-xml/Compound/dblink[dblink-db="CHEBI"]
CRP-cyclic-AMP DNA-binding transcriptional dual regulator
EcoCyc:CPLX0-226
has_part

The native component slot links this exact ligand-bound regulator to this component. No missing ligand coefficient is supplied by inference.

DNA-binding transcriptional dual regulator CRP
EcoCyc:PC00004
  • EcoCyc:CPLX0-226

    Source assertion: The native component slot links this exact ligand-bound regulator to this component. No missing ligand coefficient is supplied by inference.

    Source locationXPath /ptools-xml/Protein/component
CRP-cyclic-AMP DNA-binding transcriptional dual regulator
EcoCyc:CPLX0-226
has_part

The native component slot links this exact ligand-bound regulator to this component. No missing ligand coefficient is supplied by inference.

3',5'-cyclic AMP(1-)
CHEBI:58165
  • EcoCyc:CPLX0-226

    Source assertion: The native component slot links this exact ligand-bound regulator to this component. No missing ligand coefficient is supplied by inference.

    Source locationXPath /ptools-xml/Protein/component
  • EcoCyc:CAMP

    Source assertion: The native compound cross-reference grounds the exact ChEBI species used for this assembly component; a generic assay effector is not silently assigned its anomer.

    Source locationXPath /ptools-xml/Compound/dblink[dblink-db="CHEBI"]
DNA-binding transcriptional dual regulator Cra
EcoCyc:PC00061

experimental construct: 1996 six-His FruR/Cra in binding-site selection and pfkA analysis; source-described tetramer, not a sequenced untagged MG1655 control. Exact construct details are limited to the inspected abstract; native promoter/site joins provide separate gene-specific context.

Qualification evidence
  • PMID:8858581

    Source assertion: The primary abstract specifies six-His FruR, asymmetric consensus/operator binding, tetramer context and negative pfkA regulation.

    Source locationresultList.result[id='8858581'].abstractText
inhibits

The native mode is negative for Cra regulation of the pfkA promoter. This and REG0-4838 represent the same BS785 biological-site context rather than two independent mechanisms.

pfkA
Entrez:948412
  • EcoCyc:REG0-15081

    Source assertion: The native mode is negative for Cra regulation of the pfkA promoter. This and REG0-4838 represent the same BS785 biological-site context rather than two independent mechanisms.

    Source locationXPath /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulated-entity
  • EcoCyc:TU0-45236

    Source assertion: The exact transcription unit joins promoter PM0-46536, binding site BS785 and pfkA gene EG10699.

    Source locationXPath /ptools-xml/Transcription-Unit/component
  • PMID:8858581

    Source assertion: The source specifically identifies pfkA as negatively regulated by FruR after consensus/operator binding experiments.

    Source locationresultList.result[id='8858581'].abstractText
  • Entrez:948412

    Source assertion: The issuing Gene record grounds the pfkA expression endpoint, b3916 in MG1655; BW25113 or historical assay preparations remain separate.

    Source locationXPath /Entrezgene-Set/Entrezgene
DNA-binding transcriptional dual regulator Cra
EcoCyc:PC00061
inhibits

Native operon-mediated fbaA repression through the epd promoter. REG0-5630 and REG0-15233 share the biological epd site context. The broader1996 FruR abstract supports the regulon, but is not used as a gene-specific quote absent from its text.

fbaA
Entrez:947415
  • EcoCyc:REG0-15233

    Source assertion: Native Cra regulation of the epd promoter is negative. Its effect on fbaA is carried through the epd-pgk-fbaA transcriptional unit, not a demonstrated separate fbaA operator.

    Source locationXPath /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulated-entity
  • EcoCyc:TU0-45273

    Source assertion: The native epd promoter transcription unit includes EG10282 (fbaA), EG10703 (pgk) and EG10368 (epd). Shared promoter entries are not distinct regulatory mechanisms.

    Source locationXPath /ptools-xml/Transcription-Unit/component
  • Entrez:947415

    Source assertion: The issuing Gene record grounds fbaA/b2925 as the expression endpoint; it does not establish direct binding at an isolated fbaA promoter.

    Source locationXPath /Entrezgene-Set/Entrezgene
D-fructofuranose 1-phosphate(2-)
CHEBI:58674
inhibits

Source-limited inhibition of Cra operator binding by generic F1P; assay anomer/protonation is not measured. Older FBP-effector discussions and the later negative result remain explicit. No FBP→Cra inhibition edge is inferred.

DNA-binding transcriptional dual regulator Cra
EcoCyc:PC00061

experimental construct: 2018 source-described E. coli Cra preparation in thermal-shift, microscale-thermophoresis and EMSA assays. Only the primary abstract was acquired: tag/cleavage/sequence details are unresolved. The native reference tetramer does not assert the exact assay material.

Qualification evidence
  • PMID:29923648

    Source assertion: The abstract identifies thermal-shift/MST and EMSA assays on Cra, with F1P and FBP comparisons; full construct methods were not acquired.

    Source locationresultList.result[id='29923648'].abstractText
  • PMID:29923648

    Source assertion: F1P impairs Cra DNA-binding affinity, while FBP neither binds Cra nor impairs its operator binding in the reported tests. The paper also studies a distinct Bacillus CggR protein whose FBP response is not transferred to Cra.

    Source locationresultList.result[id='29923648'].abstractText
  • EcoCyc:D-fructofuranose-1-phosphate

    Source assertion: The independent native generic D-fructofuranose1P class links CHEBI58674. The separate FRU1P beta species belongs only to the source-defined ligand complex.

    Source locationXPath /ptools-xml/Compound/dblink[dblink-db="CHEBI"]
CRP-cyclic-AMP DNA-binding transcriptional dual regulator
EcoCyc:CPLX0-226
activates

Positive native operon-associated expression effect. In the inspected1998 abstract, the glucose response is indirect; no direct fbaA-promoter activation or universal CRP sign is asserted. REG0-5629 is the same biological promoter context.

fbaA
Entrez:947415
  • EcoCyc:REG0-15234

    Source assertion: The native epd promoter regulation has positive mode for cAMP-CRP; the fbaA endpoint is linked by the operon, not a distinct bound fbaA promoter.

    Source locationXPath /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulated-entity
  • EcoCyc:TU0-45273

    Source assertion: The epd-pgk-fbaA transcription unit provides the source path to fbaA.

    Source locationXPath /ptools-xml/Transcription-Unit/component
  • PMID:9851989

    Source assertion: In glucose, deleting the CRP-cAMP site had little effect, whereas crp or cya loss strongly reduced gapB/epd P0 activity. The authors infer an indirect CRP-cAMP effect under these conditions.

    Source locationresultList.result[id='9851989'].abstractText
  • Entrez:947415

    Source assertion: The exact issuing fbaA record grounds the downstream operon expression endpoint.

    Source locationXPath /Entrezgene-Set/Entrezgene
PTS system glucose-specific EIICB component
UniProtKB:P69786
activates

Indirect glucose/PTS-associated operon expression context via PtsG. It is not a pathway-specific S7P transporter, direct fbaA DNA interaction or a crr/EIIA assignment.

fbaA
Entrez:947415
  • PMID:9851989

    Source assertion: Glucose stimulation of gapB/epd P0 depends on ptsG-encoded EIIGlc. This is expression-system evidence, not a purified direct DNA-binding or enzyme-activation assay.

    Source locationresultList.result[id='9851989'].abstractText
  • EcoCyc:TU0-45273

    Source assertion: The source transcription unit links the epd promoter to fbaA, preserving the indirect operon context.

    Source locationXPath /ptools-xml/Transcription-Unit/component
  • UniProtKB:P69786

    Source assertion: The issuing protein entry identifies ptsG IICBGlc; the separate crr IIA chain is not substituted.

    Source locationentry[primaryAccession='P69786'].genes,organism,sequence
  • Entrez:945651

    Source assertion: This is the exact ptsG subject-reference gene identity, not the fbaA object endpoint.

    Source locationXPath /Entrezgene-Set/Entrezgene
  • Entrez:947415

    Source assertion: This is the fbaA expression object identity.

    Source locationXPath /Entrezgene-Set/Entrezgene
RNA polymerase sigma factor RpoS
UniProtKB:P13445

experimental construct: 2009 His-tagged RpoS from pET28b+ in ER2566, combined with commercial RNAP core (core:sigma1:5) for pfkA-promoter transcription. The isolated reference sigma chain is not an autonomous polymerase; exact source construct and reconstituted system delimit this claim.

Qualification evidence
  • PMID:19838295

    Source assertion: Methods distinguish purified tagged sigma-factor preparations and reconstitution with RNA polymerase core for in-vitro transcription.

    Source locationXPath /article/body/sec[4]/sec[9]/p[2] | /article/body/sec[4]/sec[9]/p[3]
activates

Reconstituted RNAP with RpoS supports transcription from the tested first pfkA promoter; sigma-dependent activity belongs to the assembled assay system.

pfkA
Entrez:948412
  • PMID:19838295

    Source assertion: Reconstituted RNAP with RpoS supports transcription from the tested first pfkA promoter; sigma-dependent activity belongs to the assembled assay system.

    Source locationXPath /article/body/sec[2]/sec[6]/p[2] | /article/body/sec[2]/sec[6]/fig[2]
  • Entrez:948412

    Source assertion: The issuing pfkA gene is the expression endpoint; this mapping does not identify every promoter-template construct as the current reference sequence.

    Source locationXPath /Entrezgene-Set/Entrezgene
RNA polymerase sigma factor RpoD
UniProtKB:P00579

experimental construct: 2009 His-tagged RpoD from pET28b+ in ER2566, combined with commercial RNAP core (core:sigma1:5) for pfkA-promoter transcription. The isolated reference sigma chain is not an autonomous polymerase; exact source construct and reconstituted system delimit this claim.

Qualification evidence
  • PMID:19838295

    Source assertion: Methods distinguish purified tagged sigma-factor preparations and reconstitution with RNA polymerase core for in-vitro transcription.

    Source locationXPath /article/body/sec[4]/sec[9]/p[2] | /article/body/sec[4]/sec[9]/p[3]
activates

Reconstituted RNAP with RpoD supports transcription from the tested first pfkA promoter; sigma-dependent activity belongs to the assembled assay system.

pfkA
Entrez:948412
  • PMID:19838295

    Source assertion: Reconstituted RNAP with RpoD supports transcription from the tested first pfkA promoter; sigma-dependent activity belongs to the assembled assay system.

    Source locationXPath /article/body/sec[2]/sec[6]/p[2] | /article/body/sec[2]/sec[6]/fig[2]
  • Entrez:948412

    Source assertion: The issuing pfkA gene is the expression endpoint; this mapping does not identify every promoter-template construct as the current reference sequence.

    Source locationXPath /Entrezgene-Set/Entrezgene
RNA polymerase sigma factor RpoS
UniProtKB:P13445

experimental construct: 2009 JM101-derived PB11/PB12 ΔptsH ptsI crr backgrounds and rpoS derivatives during aerobic M9 glucose growth. The RpoS subject denotes an expression contrast, not purified binding or the BW25113 talAB bypass cohort.

Qualification evidence
  • PMID:19838295

    Source assertion: The source compares JM101, PTS-deficient PB11/PB12 and their rpoS derivatives under specified glucose-growth conditions.

    Source locationXPath /article/body/sec[4]/sec[1]/p
activates

Condition-specific RpoS-associated fbaA expression, distinct from direct reconstituted pfkA transcription. Failure to find an immediate fbaA promoter here is not general promoter absence.

fbaA
Entrez:947415
  • PMID:19838295

    Source assertion: The pgk/fbaA expression and promoter analysis provides RpoS-associated context; an immediate fbaA promoter was not found under the tested conditions. Operon and indirect effects remain possible.

    Source locationXPath /article/body/sec[2]/sec[2]/sec[6]/p | /article/body/sec[3]/sec[2]/p
  • Entrez:947415

    Source assertion: The issuing fbaA gene grounds this expression endpoint, not an independently proven direct RpoS-binding site.

    Source locationXPath /Entrezgene-Set/Entrezgene
Carbon storage regulator
UniProtKB:P69913

experimental construct: 2016 isogenic csrA51 hypomorph versus source wild type, M9 glucose; attenuated CsrA, not a complete deletion. Subject is a reference anchor for expression/rescue inference. The abstract/native annotation does not identify a direct pfkA RNA-binding site.

Qualification evidence
  • PMID:26833659

    Source assertion: The primary abstract compares a CsrA-attenuated strain to its wild type, with PfkA restoration/rescue; it does not specify a direct pfkA RNA-binding site.

    Source locationresultList.result[id='26833659'].abstractText
  • EcoCyc:6PFK-1-CPX

    Source assertion: The native comment explicitly identifies the csrA51 hypomorphic allele and M9 glucose context.

    Source locationXPath /ptools-xml/Protein/comment
activates

CsrA attenuation disrupts upper glycolysis; restoring PfkA activity suppresses glucose-phosphate stress and increases growth. This supports a positive expression contribution, not a new physical RNA-binding claim.

pfkA
Entrez:948412
  • PMID:26833659

    Source assertion: CsrA attenuation disrupts upper glycolysis; restoring PfkA activity suppresses glucose-phosphate stress and increases growth. This supports a positive expression contribution, not a new physical RNA-binding claim.

    Source locationresultList.result[id='26833659'].abstractText
  • EcoCyc:6PFK-1-CPX

    Source assertion: The source states that pfkA expression is reduced in csrA51 and that PfkA overexpression partially rescues its growth defect.

    Source locationXPath /ptools-xml/Protein/comment
  • Entrez:947176

    Source assertion: The exact issuing csrA gene grounds the subject-reference mapping, not the pfkA object.

    Source locationXPath /Entrezgene-Set/Entrezgene
  • Entrez:948412

    Source assertion: The exact issuing pfkA gene grounds the expression object.

    Source locationXPath /Entrezgene-Set/Entrezgene
Cytochrome bo(3) ubiquinol oxidase subunit 2
UniProtKB:P0ABJ1

experimental construct: 2011 BW25113 Keio cyoA deletion versus source wild type in aerobic continuous glucose culture: D0.2 h−1,37 °C,pH7,DO35–40%, C/N1.68 or8.42. Reference protein is an anchor for indirect knockout inference, not a tested purified active-state species.

Qualification evidence
  • PMID:21272324

    Source assertion: Methods identify BW25113 Keio single deletions and the aerobic continuous-culture conditions; multiple network effects can mediate expression changes.

    Source locationXPath /collection/document/passage[51]
inhibits

Conditional transcript effect from a single-deletion comparison, not direct DNA binding or evidence of a universal regulatory sign. The Fnr contrast under oxygen does not imply the canonical anaerobic [4Fe-4S] active state. C/N-specific comparisons and network interpretations remain in source context.

pfkA
Entrez:948412
  • PMID:21272324

    Source assertion: The cyoA deletion comparison reports increased pfkA transcript. The negative reference-associated expression sign is inferred from the loss-of-function contrast and may be indirect; no pfkA binding experiment is supplied.

    Source locationXPath /collection/document/passage[19] | /collection/document/passage[35]
  • Entrez:945080

    Source assertion: The issuing cyoA gene grounds this subject-reference mapping. It is not the pfkA expression endpoint.

    Source locationXPath /Entrezgene-Set/Entrezgene
  • UniProtKB:P0ABJ1

    Source assertion: The issuing entry links cyoA to this exact reference protein; it does not establish that the deletion assay contained an isolated active assembly.

    Source locationentry[primaryAccession='P0ABJ1'].genes,organism,sequence
  • Entrez:948412

    Source assertion: The issuing pfkA gene is the expression object.

    Source locationXPath /Entrezgene-Set/Entrezgene
Cytochrome bd-I ubiquinol oxidase subunit 2
UniProtKB:P0ABK2

experimental construct: 2011 BW25113 Keio cydB deletion versus source wild type in aerobic continuous glucose culture: D0.2 h−1,37 °C,pH7,DO35–40%, C/N1.68 or8.42. Reference protein is an anchor for indirect knockout inference, not a tested purified active-state species.

Qualification evidence
  • PMID:21272324

    Source assertion: Methods identify BW25113 Keio single deletions and the aerobic continuous-culture conditions; multiple network effects can mediate expression changes.

    Source locationXPath /collection/document/passage[51]
inhibits

Conditional transcript effect from a single-deletion comparison, not direct DNA binding or evidence of a universal regulatory sign. The Fnr contrast under oxygen does not imply the canonical anaerobic [4Fe-4S] active state. C/N-specific comparisons and network interpretations remain in source context.

pfkA
Entrez:948412
  • PMID:21272324

    Source assertion: The cydB deletion comparison reports increased pfkA transcript. The negative reference-associated expression sign is inferred from the loss-of-function contrast and may be indirect; no pfkA binding experiment is supplied.

    Source locationXPath /collection/document/passage[19] | /collection/document/passage[35]
  • Entrez:945347

    Source assertion: The issuing cydB gene grounds this subject-reference mapping. It is not the pfkA expression endpoint.

    Source locationXPath /Entrezgene-Set/Entrezgene
  • UniProtKB:P0ABK2

    Source assertion: The issuing entry links cydB to this exact reference protein; it does not establish that the deletion assay contained an isolated active assembly.

    Source locationentry[primaryAccession='P0ABK2'].genes,organism,sequence
  • Entrez:948412

    Source assertion: The issuing pfkA gene is the expression object.

    Source locationXPath /Entrezgene-Set/Entrezgene
Fumarate and nitrate reduction regulatory protein
UniProtKB:P0A9E5

experimental construct: 2011 BW25113 Keio fnr deletion versus source wild type in aerobic continuous glucose culture: D0.2 h−1,37 °C,pH7,DO35–40%, C/N1.68 or8.42. Reference protein is an anchor for indirect knockout inference, not a tested purified active-state species.

Qualification evidence
  • PMID:21272324

    Source assertion: Methods identify BW25113 Keio single deletions and the aerobic continuous-culture conditions; multiple network effects can mediate expression changes.

    Source locationXPath /collection/document/passage[51]
inhibits

Conditional transcript effect from a single-deletion comparison, not direct DNA binding or evidence of a universal regulatory sign. The Fnr contrast under oxygen does not imply the canonical anaerobic [4Fe-4S] active state. C/N-specific comparisons and network interpretations remain in source context.

pfkA
Entrez:948412
  • PMID:21272324

    Source assertion: The fnr deletion comparison reports increased pfkA transcript. The negative reference-associated expression sign is inferred from the loss-of-function contrast and may be indirect; no pfkA binding experiment is supplied.

    Source locationXPath /collection/document/passage[25] | /collection/document/passage[37]
  • Entrez:945908

    Source assertion: The issuing fnr gene grounds this subject-reference mapping. It is not the pfkA expression endpoint.

    Source locationXPath /Entrezgene-Set/Entrezgene
  • UniProtKB:P0A9E5

    Source assertion: The issuing entry links fnr to this exact reference protein; it does not establish that the deletion assay contained an isolated active assembly.

    Source locationentry[primaryAccession='P0A9E5'].genes,organism,sequence
  • Entrez:948412

    Source assertion: The issuing pfkA gene is the expression object.

    Source locationXPath /Entrezgene-Set/Entrezgene
Ferric uptake regulation protein
UniProtKB:P0A9A9

experimental construct: 2011 BW25113 Keio fur deletion versus source wild type in aerobic continuous glucose culture: D0.2 h−1,37 °C,pH7,DO35–40%, C/N1.68 or8.42. Reference protein is an anchor for indirect knockout inference, not a tested purified active-state species.

Qualification evidence
  • PMID:21272324

    Source assertion: Methods identify BW25113 Keio single deletions and the aerobic continuous-culture conditions; multiple network effects can mediate expression changes.

    Source locationXPath /collection/document/passage[51]
inhibits

Conditional transcript effect from a single-deletion comparison, not direct DNA binding or evidence of a universal regulatory sign. The Fnr contrast under oxygen does not imply the canonical anaerobic [4Fe-4S] active state. C/N-specific comparisons and network interpretations remain in source context.

pfkA
Entrez:948412
  • PMID:21272324

    Source assertion: The fur deletion comparison reports increased pfkA transcript. The negative reference-associated expression sign is inferred from the loss-of-function contrast and may be indirect; no pfkA binding experiment is supplied.

    Source locationXPath /collection/document/passage[29]
  • Entrez:945295

    Source assertion: The issuing fur gene grounds this subject-reference mapping. It is not the pfkA expression endpoint.

    Source locationXPath /Entrezgene-Set/Entrezgene
  • UniProtKB:P0A9A9

    Source assertion: The issuing entry links fur to this exact reference protein; it does not establish that the deletion assay contained an isolated active assembly.

    Source locationentry[primaryAccession='P0A9A9'].genes,organism,sequence
  • Entrez:948412

    Source assertion: The issuing pfkA gene is the expression object.

    Source locationXPath /Entrezgene-Set/Entrezgene
beta-D-fructofuranose 6-phosphate(2-)
CHEBI:57634
activates

Positive cooperative response to canonical F6P substrate; this does not establish that F6P activates S7P phosphorylation or imply a separate allosteric ligand mechanism.

6-phosphofructokinase 1
EcoCyc:6PFK-1-CPX
  • EcoCyc:REG0-7476

    Source assertion: The native positive regulation names FRUCTOSE-6P for canonical phosphofructokinase activity. This preserves cooperative substrate response, not an independent S7P-effector experiment.

    Source locationXPath /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulated-entity
  • EcoCyc:FRUCTOSE-6P

    Source assertion: The exact native compound identifies beta-D-fructofuranose6-phosphate with CHEBI57634, charge−2 and matching formula/InChI. Its inconsistent CML SMILES is not used to override the native identity.

    Source locationXPath /ptools-xml/Compound/common-name | /ptools-xml/Compound/dblink[dblink-db="CHEBI"] | /ptools-xml/Compound/cml | /ptools-xml/Compound/inchi
MetaCyc:PWY0-1517has_part

The exact frozen native bypass root attaches this named child. This is source structural membership, not an extra core reaction, transport or independently inferred causal direction.

Pentose Phosphate
PathBank:SMP0121065
  • PathBank:SMP0002110

    Source assertion: The exact frozen native bypass root attaches this named child. This is source structural membership, not an extra core reaction, transport or independently inferred causal direction.

    Source locationXPath //*[local-name()="Pathway"][@*[local-name()="about"]="http://identifiers.org/smpdb/SMP0002110"]/*[local-name()="pathwayComponent"][@*[local-name()="resource"]="http://identifiers.org/smpdb/SMP0121065"]
MetaCyc:PWY0-1517has_part

The exact frozen native bypass root attaches this named child. This is source structural membership, not an extra core reaction, transport or independently inferred causal direction.

Glycolysis and Pyruvate Dehydrogenase
PathBank:SMP0000807
  • PathBank:SMP0002110

    Source assertion: The exact frozen native bypass root attaches this named child. This is source structural membership, not an extra core reaction, transport or independently inferred causal direction.

    Source locationXPath //*[local-name()="Pathway"][@*[local-name()="about"]="http://identifiers.org/smpdb/SMP0002110"]/*[local-name()="pathwayComponent"][@*[local-name()="resource"]="http://identifiers.org/smpdb/SMP0000807"]
Pentose Phosphate
PathBank:SMP0121065
has_part

Unsigned structural participant context, using the exact native local compound. Native neutral S7P/E4P and dilithium DHAP remain distinct from the Rhea anions. The generic Interaction supplies no transport mechanism, regulatory sign or extra stoichiometric conversion.

D-Sedoheptulose 7-phosphate
PathBank:SMP0002110/Compound/PW_C000843
  • PathBank:SMP0002110

    Source assertion: This child has a generic Interaction whose sole participant is exact local compound PW_C000843, associated with S7P input to the bypass. A source SubPathwayInput/Output marker is not inhibition or a biochemical side.

    Source locationXPath //*[local-name()="Pathway"][@*[local-name()="about"]="http://identifiers.org/smpdb/SMP0121065"] | //*[local-name()="Interaction"][@*[local-name()="ID"]="SubPathwayInteractions/109963"] | //*[local-name()="SmallMolecule"][@*[local-name()="ID"]="Compound/PW_C000843"] | //*[local-name()="SmallMoleculeReference"][@*[local-name()="ID"]="CompoundReference/PW_C000843"]
Pentose Phosphate
PathBank:SMP0121065
has_part

Unsigned structural participant context, using the exact native local compound. Native neutral S7P/E4P and dilithium DHAP remain distinct from the Rhea anions. The generic Interaction supplies no transport mechanism, regulatory sign or extra stoichiometric conversion.

D-Erythrose 4-phosphate
PathBank:SMP0002110/Compound/PW_C001019
  • PathBank:SMP0002110

    Source assertion: This child has a generic Interaction whose sole participant is exact local compound PW_C001019, associated with E4P output from the bypass. A source SubPathwayInput/Output marker is not inhibition or a biochemical side.

    Source locationXPath //*[local-name()="Pathway"][@*[local-name()="about"]="http://identifiers.org/smpdb/SMP0121065"] | //*[local-name()="Interaction"][@*[local-name()="ID"]="SubPathwayInteractions/109888"] | //*[local-name()="SmallMolecule"][@*[local-name()="ID"]="Compound/PW_C001019"] | //*[local-name()="SmallMoleculeReference"][@*[local-name()="ID"]="CompoundReference/PW_C001019"]
Glycolysis and Pyruvate Dehydrogenase
PathBank:SMP0000807
has_part

Unsigned structural participant context, using the exact native local compound. Native neutral S7P/E4P and dilithium DHAP remain distinct from the Rhea anions. The generic Interaction supplies no transport mechanism, regulatory sign or extra stoichiometric conversion.

Glycerone phosphate
PathBank:SMP0002110/Compound/PW_C042631
  • PathBank:SMP0002110

    Source assertion: This child has a generic Interaction whose sole participant is exact local compound PW_C042631, associated with DHAP output from the bypass. A source SubPathwayInput/Output marker is not inhibition or a biochemical side.

    Source locationXPath //*[local-name()="Pathway"][@*[local-name()="about"]="http://identifiers.org/smpdb/SMP0000807"] | //*[local-name()="Interaction"][@*[local-name()="ID"]="SubPathwayInteractions/109887"] | //*[local-name()="SmallMolecule"][@*[local-name()="ID"]="Compound/PW_C042631"] | //*[local-name()="SmallMoleculeReference"][@*[local-name()="ID"]="CompoundReference/PW_C042631"]

References

Curation history